Zscaler (ZS) 10-Q 5 Dec 24 2025 Q1 Quarterly report Financial data

Cover Page

Cover Page - shares	3 Months Ended
	Oct. 31, 2024	Nov. 30, 2024
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Oct. 31, 2024
Document Transition Report	false
Entity File Number	001-38413
Entity Registrant Name	ZSCALER, INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	26-1173892
Entity Address, Address Line One	120 Holger Way
Entity Address, City or Town	San Jose
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	95134
City Area Code	408
Local Phone Number	533-0288
Title of 12(b) Security	Common Stock, $0.001 Par Value
Trading Symbol	ZS
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Shares Outstanding		153,438,623
Entity Central Index Key	0001713683
Current Fiscal Year End Date	--07-31
Document Fiscal Year Focus	2025
Document Fiscal Period Focus	Q1
Amendment Flag	false

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Oct. 31, 2024	Jul. 31, 2024
Current assets:
Cash and cash equivalents	$ 1,553,645	$ 1,423,080
Short-term investments	1,154,252	986,574
Accounts receivable, net	424,573	736,529
Deferred contract acquisition costs	152,475	148,873
Prepaid expenses and other current assets	108,835	101,561
Total current assets	3,393,780	3,396,617
Property and equipment, net	409,005	383,121
Operating lease right-of-use assets	84,091	89,758
Deferred contract acquisition costs, noncurrent	286,656	296,525
Acquired intangible assets, net	59,595	63,835
Goodwill	417,029	417,029
Other noncurrent assets	58,846	58,083
Total assets	4,709,002	4,704,968
Current liabilities:
Accounts payable	25,368	23,309
Accrued expenses and other current liabilities	83,384	91,708
Accrued compensation	126,379	160,810
Deferred revenue	1,533,080	1,643,919
Convertible senior notes	1,145,799	1,142,275
Operating lease liabilities	49,600	50,866
Total current liabilities	2,963,610	3,112,887
Deferred revenue, noncurrent	250,640	251,055
Operating lease liabilities, noncurrent	41,938	44,824
Other noncurrent liabilities	24,269	22,100
Total liabilities	3,280,457	3,430,866
Commitments and contingencies (Note 10)
Stockholders’ Equity
Preferred stock; $0.001 par value; 200,000 shares authorized as of October 31, 2024 and July 31, 2024; no shares issued and outstanding as of October 31, 2024 and July 31, 2024	0	0
Common stock; $0.001 par value; 1,000,000 shares authorized as of October 31, 2024 and July 31, 2024; 153,415 and 152,490 shares issued and outstanding as of October 31, 2024 and July 31, 2024, respectively	153	152
Additional paid-in capital	2,593,010	2,426,819
Accumulated other comprehensive loss	(4,487)	(4,789)
Accumulated deficit	(1,160,131)	(1,148,080)
Total stockholders’ equity	1,428,545	1,274,102
Total liabilities and stockholders’ equity	$ 4,709,002	$ 4,704,968

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Oct. 31, 2024	Jul. 31, 2024
Statement of Financial Position [Abstract]
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized (in shares)	200,000,000	200,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized (in shares)	1,000,000,000	1,000,000,000
Common stock, shares issued (in shares)	153,415,000	152,490,000
Common stock, shares outstanding (in shares)	153,415,000	152,490,000

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Oct. 31, 2024	Oct. 31, 2023
Income Statement [Abstract]
Revenue	$ 627,955	$ 496,703
Cost of revenue	141,462	111,394
Gross profit	486,493	385,309
Operating expenses:
Sales and marketing	306,087	267,111
Research and development	154,254	113,539
General and administrative	56,819	50,716
Total operating expenses	517,160	431,366
Loss from operations	(30,667)	(46,057)
Interest income	30,048	25,942
Interest expense	(3,143)	(3,159)
Other expense, net	(652)	(1,212)
Loss before income taxes	(4,414)	(24,486)
Provision for income taxes	7,637	8,997
Net loss	$ (12,051)	$ (33,483)
Net loss per share, basic and diluted
Net loss per share, basic (in dollars per share)	$ (0.08)	$ (0.23)
Net loss per share, diluted (in dollars per share)	$ (0.08)	$ (0.23)
Weighted-average shares used in computing net loss per share, basic and diluted
Basic (in shares)	152,557	147,625
Diluted (in shares)	152,557	147,625

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended
	Oct. 31, 2024	Oct. 31, 2023
Statement of Comprehensive Income [Abstract]
Net loss	$ (12,051)	$ (33,483)
Available-for-sale securities:
Change in net unrealized gains (losses) on available-for-sale securities	1,041	(589)
Cash flow hedging instruments:
Change in net unrealized gains (losses)	469	(15,136)
Net realized gains reclassified into net loss	(1,208)	(654)
Net change on cash flow hedges	(739)	(15,790)
Other comprehensive income (loss)	302	(16,379)
Comprehensive loss	$ (11,749)	$ (49,862)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Stockholders' Equity - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit
Beginning balance (in shares) at Jul. 31, 2023		147,169
Beginning balance at Jul. 31, 2023	$ 725,112	$ 147	$ 1,816,915	$ (1,576)	$ (1,090,374)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		151
Issuance of common stock upon exercise of stock options	1,256		1,256
Vesting of restricted stock units, performance stock awards and other stock issuances (in shares)		993
Vesting of restricted stock units, performance stock awards and other stock issuances	0	$ 1	(1)
Stock-based compensation	131,019		131,019
Other comprehensive income (loss)	(16,379)			(16,379)
Net loss	(33,483)				(33,483)
Ending balance (in shares) at Oct. 31, 2023		148,313
Ending balance at Oct. 31, 2023	$ 807,525	$ 148	1,949,189	(17,955)	(1,123,857)
Beginning balance (in shares) at Jul. 31, 2024	152,490	152,490
Beginning balance at Jul. 31, 2024	$ 1,274,102	$ 152	2,426,819	(4,789)	(1,148,080)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)	87	87
Issuance of common stock upon exercise of stock options	$ 890		890
Vesting of restricted stock units, performance stock awards and other stock issuances (in shares)		838
Vesting of restricted stock units, performance stock awards and other stock issuances	0	$ 1	(1)
Stock-based compensation	165,302		165,302
Other comprehensive income (loss)	302			302
Net loss	$ (12,051)				(12,051)
Ending balance (in shares) at Oct. 31, 2024	153,415	153,415
Ending balance at Oct. 31, 2024	$ 1,428,545	$ 153	$ 2,593,010	$ (4,487)	$ (1,160,131)

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Oct. 31, 2024	Oct. 31, 2023
Cash Flows From Operating Activities
Net loss	$ (12,051)	$ (33,483)
Adjustments to reconcile net loss to cash provided by operating activities:
Depreciation and amortization expense	21,423	13,962
Amortization expense of acquired intangible assets	4,240	3,036
Amortization of deferred contract acquisition costs	39,068	30,111
Amortization of debt issuance costs	981	977
Non-cash operating lease costs	15,657	9,903
Stock-based compensation expense	157,178	129,138
Accretion of investments purchased at a discount	(5,003)	(3,199)
Unrealized gains on hedging transactions	3,689	1,564
Deferred income taxes	186	(43)
Other	644	1,031
Changes in operating assets and liabilities, net of effects of business combinations:
Accounts receivable	311,975	215,082
Deferred contract acquisition costs	(32,801)	(27,680)
Prepaid expenses, other current and noncurrent assets	(8,767)	1,349
Accounts payable	1,043	4,596
Accrued expenses, other current and noncurrent liabilities	(6,240)	4,859
Accrued compensation	(34,431)	(39,232)
Deferred revenue	(111,254)	(40,154)
Operating lease liabilities	(14,202)	(11,011)
Net cash provided by operating activities	331,335	260,806
Cash Flows From Investing Activities
Purchases of property, equipment and other assets	(17,025)	(28,659)
Capitalized internal-use software	(22,429)	(7,429)
Payments for business acquisitions, net of cash acquired	0	(4,377)
Purchase of strategic investments	(561)	0
Purchases of short-term investments	(430,296)	(375,929)
Proceeds from maturities of short-term investments	268,651	253,849
Net cash used in investing activities	(201,660)	(162,545)
Cash Flows From Financing Activities
Proceeds from issuance of common stock upon exercise of stock options	890	1,256
Net cash provided by financing activities	890	1,256
Net increase in cash and cash equivalents	130,565	99,517
Cash and cash equivalents at beginning of period	1,423,080	1,262,206
Cash and cash equivalents at end of period	1,553,645	1,361,723
Supplemental Disclosure of Cash Flow Information
Cash paid for income taxes, net of tax refunds	9,399	5,286
Non-Cash Activities
Operating lease right-of-use assets obtained in exchange for operating lease obligations, net of terminations	8,894	15,617
Net change in purchased equipment included in accounts payable and accrued expenses	$ 462	$ 489

Business and Summary of Signifi

Business and Summary of Significant Accounting Policies	3 Months Ended
	Oct. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Business and Summary of Significant Accounting Policies	Business and Summary of Significant Accounting Policies Description of the Business Zscaler, Inc. ("Zscaler," the "Company," "we," "us," or "our") is a cloud security company that developed a platform incorporating core security functionalities needed to enable fast and secure access to cloud resources based on identity, context and organization’s policies. Our solution is a purpose-built, multi-tenant, distributed cloud platform that incorporates the security functionality needed to enable users, applications, and devices to safely and efficiently utilize authorized applications and services based on an organization’s business policies. We deliver our solutions using a software-as-a-service ("SaaS") business model and sell subscriptions to customers to access our cloud platform, together with related support services. We were incorporated in Delaware in September 2007 and conduct business worldwide, with presence in North America, South America, Europe and Asia. Our headquarters are in San Jose, California. Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States ("GAAP") and applicable regulations of the Securities and Exchange Commission ("SEC") regarding interim financial reporting, and include the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to the applicable required disclosures and regulations of the SEC. Therefore, these unaudited condensed consolidated financial statements and accompanying notes should be read in conjunction with the Company's audited consolidated financial statements and related notes in its Annual Report on Form 10-K for the fiscal year ended July 31, 2024 (the "Fiscal 2024 Form 10-K"), as filed with the SEC on September 12, 2024. Interim Unaudited Condensed Consolidated Financial Statements The accompanying condensed consolidated balance sheet as of July 31, 2024 was derived from the audited consolidated financial statements as of that date. The accompanying interim unaudited condensed consolidated financial statements, including the condensed consolidated balance sheet as of October 31, 2024, the condensed consolidated statements of operations for the three months ended October 31, 2024 and 2023, the condensed consolidated statements of comprehensive loss for the three months ended October 31, 2024 and 2023, the condensed consolidated statements of stockholders’ equity for the three months ended October 31, 2024 and 2023 and the condensed consolidated statements of cash flows for the three months ended October 31, 2024 and 2023 are unaudited. The related financial data and the other financial information disclosed in the accompanying notes to these interim unaudited condensed consolidated financial statements are also unaudited. These interim unaudited condensed consolidated financial statements have been prepared on a basis consistent with our annual consolidated financial statements and, in our opinion, include all normal recurring adjustments necessary to state fairly our quarterly results. The results of operations for the three months ended October 31, 2024 are not necessarily indicative of the results to be expected for our fiscal year ending July 31, 2025 or for any other future fiscal year or interim period. Use of Estimates The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates, judgments and assumptions that affect the amounts reported and disclosed in the financial statements and accompanying notes. Such estimates include, but are not limited to, the determination of revenue recognition, deferred revenue, deferred contract acquisition costs, capitalized internal-use software, valuation of acquired intangible assets, period of benefit generated from our deferred contract acquisition costs, allowance for doubtful accounts, valuation of common stock options and stock-based awards, useful lives of property and equipment, useful lives of acquired intangible assets, recoverability of goodwill, valuation of deferred tax assets and liabilities, loss contingencies related to litigation, fair value of convertible senior notes and the discount rate used for operating leases. Management determines these estimates and assumptions based on historical experience and on various other assumptions that are believed to be reasonable. Actual results could differ significantly from these estimates, and such differences may be material to the condensed consolidated financial statements. Due to uncertainty in the macroeconomic and geopolitical environment, there is ongoing disruption in the global economy and financial markets. We are not aware of any specific event or circumstances that would require an update to our estimates, judgments or assumptions or a revision to the carrying value of our assets or liabilities as of the date of issuance of these condensed consolidated financial statements. These estimates, judgments and assumptions may change in the future, as new events occur or additional information is obtained . Fiscal Year Our fiscal year ends on July 31. References to fiscal 2025, for example, refer to our fiscal year ending July 31, 2025. Significant Accounting Polici es Our significant accounting policies are described in the Fiscal 2024 Form 10-K. There have been no significant changes to these policies that have had a material impact on the condensed consolidated financial statements and related notes for the three months ended October 31, 2024. Recently Issued Accounting Pronouncements Not Yet Adopted In November 2023, the Financial Accounting Standards Board ("FASB") issued ASU No. 2023-07, Segment Reporting (Topic 280 ): Improvements to Reportable Segment Disclosures , which requires disclosure of incremental segment information on an annual and interim basis. Th is standard is effective for us in the annual periods beginning in fiscal 2025 and interim periods beginning in the first quarter of fiscal 2026. We are currently evaluating the potential impact of this standard on our consolidated financial statement disclosures. In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. The amended guidance enhances income tax disclosures primarily related to the effective tax rate reconciliation and income taxes paid information. This standard requires disclosures of specific categories in the effective tax rate reconciliation and further information on reconciling items meeting a quantitative threshold. In addition, the amended guidance requires disaggregating income taxes paid (net of refunds received) by federal, state and foreign taxes. It also requires disaggregating individual jurisdictions in which income taxes paid (net of refunds received) is equal to or greater than 5% of total income taxes paid (net of refunds received). This standard is effective for us in the annual periods beginning in fiscal 2026 . We are currently evaluating the potential impact of this standard on our consolidated financial statement disclosures. In November 2024, the FASB issued ASU No. 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40), Disaggregation of Income Statement Expenses . This standard requires disclosures of additional information about specific expense categories in the notes to the financial statements for interim and annual reporting periods . This standard is effective for us in the annual periods beginning in fiscal 2028 and interim periods beginning in the first quarter of fiscal 2029. We are currently evaluating the potential impact of this standard on our consolidated financial statement disclosures.

Revenue Recognition

Revenue Recognition	3 Months Ended
	Oct. 31, 2024
Revenue from Contract with Customer [Abstract]
Revenue Recognition	Revenue Recognition Disaggregation of Revenue Subscription and support revenue is recognized over time and accounted for approximately 97% of our revenue for the three months ended October 31, 2024 and 2023. The following table summarizes the revenue by region based on the shipping address of customers who have contracted to use our cloud platform: Three Months Ended October 31, 2024 2023 Amount % Revenue Amount % Revenue (in thousands, except for percentage data) United States $ 319,312 51 % $ 247,531 50 % Europe, Middle East and Africa 186,069 30 % 157,245 32 % Asia Pacific 99,382 16 % 75,080 15 % Other 23,192 3 % 16,847 3 % Total $ 627,955 100 % $ 496,703 100 % The following table summarizes the revenue from contracts by type of customer: Three Months Ended October 31, 2024 2023 Amount % Revenue Amount % Revenue (in thousands, except for percentage data) Channel partners $ 558,360 89 % $ 454,456 91 % Direct customers 69,595 11 % 42,247 9 % Total $ 627,955 100 % $ 496,703 100 % Significant Customers No single customer accounted for 10% or more of the total revenue during the periods presented. The following table summarizes the concentration of 10% or more of the total balance of accounts receivable, net: October 31, 2024 July 31, 2024 Channel partner A 11% * (*) Represents less than 10%. Contract Balances Contract liabilities consist of deferred revenue and include payments received in advance of performance under the contract. Such amounts are recognized as revenue over the contractual period. Deferred revenue, including current and noncurrent balances as of October 31, 2024 and July 31, 2024 was $1,783.7 million and $1,895.0 million, respectively. In the three months ended October 31, 2024 and 2023, we recognized revenue of $595.2 million and $462.9 million, respectively, that was included in the corresponding contract liability balance at the beginning of these periods. Remaining Performance Obligations The typical subscription and support term is one Costs to Obtain and Fulfill a Contract We capitalize sales commission and associated payroll taxes paid to sales personnel that are incremental to the acquisition of customer contracts. These costs are recorded as deferred contract acquisition costs in the condensed consolidated balance sheets. The activity of the deferred contract acquisition costs consisted of the following: Three Months Ended October 31, 2024 2023 (in thousands) Beginning balance $ 445,398 $ 375,234 Capitalization of contract acquisition costs 32,801 27,680 Amortization of deferred contract acquisition costs (39,068) (30,111) Ending balance $ 439,131 $ 372,803 The outstanding balance of the deferred contract acquisition costs consisted of the following: October 31, 2024 July 31, 2024 (in thousands) Deferred contract acquisition costs, current $ 152,475 $ 148,873 Deferred contract acquisition costs, noncurrent 286,656 296,525 Total deferred contract acquisition costs $ 439,131 $ 445,398

Cash Equivalents and Short-Term

Cash Equivalents and Short-Term Investments	3 Months Ended
	Oct. 31, 2024
Cash and Cash Equivalents [Abstract]
Cash Equivalents and Short-Term Investments	Cash Equivalents and Short-Term Investments Cash equivalents and short-term investments consisted of the following as of October 31, 2024: Amortized Unrealized Unrealized Fair Value Cash equivalents: (in thousands) Money market funds $ 1,172,163 $ — $ — $ 1,172,163 U.S. treasury securities 35,898 5 — 35,903 U.S. government agency securities 107,255 3 (19) 107,239 Certificates of deposit 106,452 — — 106,452 Total cash equivalents $ 1,421,768 $ 8 $ (19) $ 1,421,757 Short-term investments: U.S. treasury securities $ 314,332 $ 59 $ (436) $ 313,955 U.S. government agency securities 183,431 92 (195) 183,328 Corporate debt securities 655,888 2,164 (1,083) 656,969 Total short-term investments $ 1,153,651 $ 2,315 $ (1,714) $ 1,154,252 Total cash equivalents and short-term investments $ 2,575,419 $ 2,323 $ (1,733) $ 2,576,009 Cash equivalents and short-term investments consisted of the following as of July 31, 2024: Amortized Unrealized Unrealized Fair Value Cash equivalents: (in thousands) Money market funds $ 956,932 $ — $ — $ 956,932 U.S. treasury securities 178,188 — (15) 178,173 U.S. government agency securities 57,555 — (6) 57,549 Certificates of deposit 80,940 — — 80,940 Total cash equivalents $ 1,273,615 $ — $ (21) $ 1,273,594 Short-term investments: U.S. treasury securities $ 257,841 $ 8 $ (828) $ 257,021 U.S. government agency securities 160,574 43 (542) 160,075 Corporate debt securities 568,589 1,514 (625) 569,478 Total short-term investments $ 987,004 $ 1,565 $ (1,995) $ 986,574 Total cash equivalents and short-term investments $ 2,260,619 $ 1,565 $ (2,016) $ 2,260,168 The amortized cost and fair value of our short-term investments based on their stated maturities consisted of the following as of October 31, 2024: Amortized Fair Value (in thousands) Due within one year $ 562,736 $ 562,907 Due between one to three years 590,915 591,345 Total $ 1,153,651 $ 1,154,252 Short-term investments that were in continuous unrealized loss position as of October 31, 2024 consisted of the following: Less than 12 Months Greater than 12 Months Total Fair Unrealized Fair Unrealized Fair Unrealized (in thousands) U.S. treasury securities $ 146,042 $ (436) $ — $ — $ 146,042 $ (436) U.S. government agency securities 127,374 (174) 11,096 (21) 138,470 (195) Corporate debt securities 166,536 (1,050) 25,384 (33) 191,920 (1,083) Total $ 439,952 $ (1,660) $ 36,480 $ (54) $ 476,432 $ (1,714) Short-term investments that were in continuous unrealized loss position as of July 31, 2024 consisted of the following: Less than 12 Months Greater than 12 Months Total Fair Unrealized Fair Unrealized Fair Unrealized (in thousands) U.S. treasury securities $ 152,574 $ (115) $ 87,808 $ (713) $ 240,382 $ (828) U.S. government agency securities 65,563 (28) 65,334 (514) 130,897 (542) Corporate debt securities 81,020 (102) 94,666 (523) 175,686 (625) Total $ 299,157 $ (245) $ 247,808 $ (1,750) $ 546,965 $ (1,995) We review the individual securities that have unrealized losses in our short-term investment portfolio on a regular basis. We evaluate, among others, whether we have the intention to sell any of these investments and whether it is not more likely than not that we will be required to sell any of them before recovery of the amortized cost basis. Neither of these criteria were met in any period presented. We additionally evaluate whether the decline in fair value of the corporate debt securities below their amortized cost basis is related to credit losses or other factors. Based on this evaluation, we determined that unrealized losses of the above securities were primarily attributable to changes in interest rates and non credit-related factors. Accordingly, we determined that an allowance for credit losses was unnecessary for our short-term investments as of October 31, 2024 and July 31, 2024. As of October 31, 2024 and July 31, 2024, we recorded $12.6 million and $10.7 million, respectively, of accrued interest receivable within prepaid expenses and other current assets in the condensed consolidated balance sheets. Strategic Investments

Fair Value Measurements

Fair Value Measurements	3 Months Ended
	Oct. 31, 2024
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements We measure our financial assets and liabilities at fair value at each reporting period using a fair value hierarchy, which requires us to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. A financial instrument’s classification within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. Our money market funds are classified within Level I due to the highly liquid nature of these assets and have quoted prices in active markets. Certain of our investments in available-for-sale securities (i.e., U.S. treasury securities, U.S. government agency securities, certificates of deposit and corporate debt securities), as well as our assets and liabilities arising from our foreign currency forward contracts and our interest rate swap contracts, are classified within Level II. The fair value of our Level II financial assets and liabilities is determined by using inputs based on non-binding market consensus prices that are primarily corroborated by observable market data or quoted market prices for similar instruments, for substantially the full term of the financial assets and liabilities. Assets and liabilities that are measured at fair value on a recurring basis consisted of the following as of October 31, 2024: Level I Level II Level III Fair Value Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs Cash equivalents: (in thousands) Money market funds $ 1,172,163 $ 1,172,163 $ — $ — U.S. treasury securities 35,903 — 35,903 — U.S. government agency securities 107,239 — 107,239 — Certificates of deposit 106,452 — 106,452 — Total cash equivalents $ 1,421,757 $ 1,172,163 $ 249,594 $ — Short-term investments: U.S. treasury securities $ 313,955 $ — $ 313,955 $ — U.S. government agency securities 183,328 — 183,328 — Corporate debt securities 656,969 — 656,969 — Total short-term investments $ 1,154,252 $ — $ 1,154,252 $ — Total cash equivalents and short-term investments $ 2,576,009 $ 1,172,163 $ 1,403,846 $ — Designated derivative instruments: Foreign currency contracts assets-current (1) $ 2,918 $ — $ 2,918 $ — Foreign currency contracts assets-noncurrent (2) $ 665 $ — $ 665 $ — Foreign currency contracts liabilities-current (3) $ 4,720 $ — $ 4,720 $ — Foreign currency contracts liabilities-noncurrent (4) $ 1,201 $ — $ 1,201 $ — Interest rate contracts liabilities-current (3) $ 1,428 $ — $ 1,428 $ — Non-designated derivative instruments: Foreign currency contracts assets-current (1) $ 745 $ — $ 745 $ — Foreign currency contracts liabilities-current (3) $ 3,492 $ — $ 3,492 $ — (1) Included within prepaid expenses and other current assets in the condensed consolidated balance sheets. (2) Included within other noncurrent assets in the condensed consolidated balance sheets. (3) Included within accrued expenses and other current liabilities in the condensed consolidated balance sheets. (4) Included within other noncurrent liabilities in the condensed consolidated balance sheets. Assets that are measured at fair value on a recurring basis consisted of the following as of July 31, 2024: Level I Level II Level III Fair Value Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs Cash equivalents: (in thousands) Money market funds $ 956,932 $ 956,932 $ — $ — U.S. treasury securities 178,173 — 178,173 — U.S. government agency securities 57,549 — 57,549 — Certificates of deposit 80,940 — 80,940 — Total cash equivalents $ 1,273,594 $ 956,932 $ 316,662 $ — Short-term investments: U.S. treasury securities $ 257,021 $ — $ 257,021 $ — U.S. government agency securities 160,075 — 160,075 — Corporate debt securities 569,478 — 569,478 — Total short-term investments $ 986,574 $ — $ 986,574 $ — Total cash equivalents and short-term investments $ 2,260,168 $ 956,932 $ 1,303,236 $ — Designated derivative instruments: Foreign currency contracts assets-current (1) $ 2,541 $ — $ 2,541 $ — Foreign currency contract assets-noncurrent (2) $ 800 $ — $ 800 $ — Foreign currency contracts liabilities-current (3) $ 3,731 $ — $ 3,731 $ — Foreign currency contracts liabilities-noncurrent (4) $ 844 $ — $ 844 $ — Interest rate contracts liabilities-current (3) $ 3,829 $ — $ 3,829 $ — Non-designated derivative instruments: Foreign currency contracts assets-current (1) $ 2,132 $ — $ 2,132 $ — Foreign currency contracts liabilities-current (3) $ 1,748 $ — $ 1,748 $ — (1) Included within prepaid expenses and other current assets in the consolidated balance sheets. (2) Included within other noncurrent assets in the consolidated balance sheets. (3) Included within accrued expenses and other current liabilities in the consolidated balance sheets. (4) Included within other noncurrent liabilities in the consolidated balance sheets. We did not have transfers between levels of the fair value hierarchy of assets measured at fair value during the periods presented. Refer to Note 9, Convertible Senior Notes, for the carrying amount and estimated fair value of our convertible senior notes as of October 31, 2024 and July 31, 2024.

Balance Sheet Components

Balance Sheet Components	3 Months Ended
	Oct. 31, 2024
Property, Plant and Equipment [Abstract]
Balance Sheet Components	Balance Sheet Components Property and Equipment and Purchased Intangible Assets Property and equipment consisted of the following: October 31, 2024 July 31, 2024 (in thousands) Hosting equipment $ 434,018 $ 418,775 Capitalized internal-use software 232,092 197,769 Computers and equipment 7,081 6,741 Purchased software 1,103 1,102 Furniture and fixtures 1,077 1,071 Leasehold improvements 8,341 7,974 Total property and equipment, gross 683,712 633,432 Less: Accumulated depreciation and amortization (274,707) (250,311) Total property and equipment, net $ 409,005 $ 383,121 Purchased intangible assets consist of internet protocol (IP) addresses and source codes, which are amortized on a straight-line basis over an estimated useful life of 10 years. As of October 31, 2024, their historical cost and accumulated amortization were $12.4 million and $3.2 million, respectively. As of July 31, 2024, their historical cost and accumulated amortization were $12.4 million and $2.8 million, respectively. Purchased intangible assets are included within other noncurrent assets in the condensed consolidated balance sheets. We recognized depreciation and amortization expense on property and equipment and purchased intangible assets of $21.4 million and $14.0 million for the three months ended October 31, 2024 and 2023, respectively. Additionally, we recognized stock-based compensation expense on the amortization of capitalized stock-based compensation associated with capitalized internal-use software of $4.2 million and $2.9 million for the three months ended October 31, 2024 and 2023, respectively. Accrued compensation Accrued compensation consisted of the following: October 31, 2024 July 31, 2024 (in thousands) Accrued commissions $ 22,045 $ 51,371 Accrued bonuses 33,372 53,452 Accrued payroll and related expenses 47,924 47,184 Employee stock purchase plan 23,038 8,803 Total accrued compensation $ 126,379 $ 160,810

Business Combinations

Business Combinations	3 Months Ended
	Oct. 31, 2024
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]
Business Combinations	Business Combinations On August 31, 2023, we completed the acquisition of Securelyshare Software Private Ltd., an early-stage technology company incorporated in India, for total purchase price consideration of $5.3 million. We have integrated this company's technology into our cloud platform. The transaction was accounted for as a business combination. We recognized intangible assets of $2.8 million for developed technology and goodwill of $3.2 million. The developed technology is amortized over its economic useful life of five years. Goodwill represents the excess of the purchase price paid over the fair value of the net assets acquired and is primarily attributable to the acquired workforce and expected operating synergies. The acquisition qualified as a stock transaction for tax purposes. The goodwill is not deductible for income tax purposes. The acquisition-related transaction expenses were not material and recorded as incurred within general and administrative expenses in the condensed consolidated statement of operations for the three months ended October 31, 2023. The pro forma financial information, assuming the acquisition had occurred as of the beginning of the fiscal year prior to the fiscal year of the acquisition, as well as revenue and earnings generated during the period after the acquisition date, were not material for disclosure purposes.

Goodwill and Acquired Intangibl

Goodwill and Acquired Intangible Assets	3 Months Ended
	Oct. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Acquired Intangible Assets	Goodwill and Acquired Intangible Assets Goodwill The carrying amount of goodwill was $417.0 million as of October 31, 2024 and July 31, 2024. Acquired Intangible Assets Acquired intangible assets consist of developed technology and customer relationships acquired through our business acquisitions. Acquired intangible assets are amortized using the straight-line method over their estimated useful lives. Changes in acquired intangible assets for the three months ended October 31, 2024 consisted of the following: Gross Carrying Amount Accumulated Amortization Net Carrying Amount Weighted Average Remaining Useful life July 31, 2024 Additions October 31, 2024 July 31, 2024 Amortization Expense October 31, 2024 July 31, 2024 October 31, 2024 October 31, 2024 (in thousands) (years) Developed technology $ 99,656 $ — $ 99,656 $ (42,651) $ (3,815) $ (46,466) $ 57,005 $ 53,190 4.0 Customer relationships 9,960 — 9,960 (3,130) (425) (3,555) 6,830 6,405 4.1 Total $ 109,616 $ — $ 109,616 $ (45,781) $ (4,240) $ (50,021) $ 63,835 $ 59,595 4.0 Amortization expense of acquired intangible assets for the three months ended October 31, 2024 and 2023 was $4.2 million and $3.0 million, respectively. Amortization expense of developed technology and customer relationships is included primarily within cost of revenue and sales and marketing expenses, respectively, in the condensed consolidated statements of operations. Future amortization expense of acquired intangible assets as of October 31, 2024 consists of the following: Amount Fiscal Year ending July 31, (in thousands) 2025 (remaining nine months) $ 12,545 2026 15,772 2027 12,948 2028 11,115 2029 7,215 Total $ 59,595

Derivative Instruments

Derivative Instruments	3 Months Ended
	Oct. 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Instruments	Derivative Instruments Foreign Currency Forward Contracts As a global business, we are exposed to foreign currency exchange rate risk. Substantially all of our revenue is transacted in U.S. dollars; however, a portion of our cost of revenue and operating expenditures are incurred outside of the United States and are denominated in foreign currencies, making them subject to fluctuations in foreign currency exchange rates. In order to mitigate the impact of foreign currency fluctuations on our future cash flows and earnings, we enter into foreign currency forward contracts, which we designate as cash flow hedges. The maximum length of time over which forecasted foreign currency denominated operating expenses are hedged is 21 months. All cash flow hedges were considered effective during the three months ended October 31, 2024 and 2023. We also use foreign currency forward contracts to mitigate variability in gains and losses generated from the remeasurement of certain monetary assets and liabilities denominated in foreign currencies. The outstanding non-designated derivative instruments are carried at fair value with the change in fair value recorded in other expense, net in the condensed consolidated statement of operations in the same period as the changes in fair value from the remeasurement of the underlying assets and liabilities. Cash flows from such derivatives are classified as operating activities. These foreign exchange contracts typically have maturities of approximately one As of October 31, 2024 and July 31, 2024, the total notional amount of our outstanding designated foreign currency forward contracts was $604.8 million and $544.5 million, respectively, and for our outstanding non-designated foreign currency forward contracts was $397.7 million and $352.8 million, respectively. As of October 31, 2024, an estimated $2.7 million of the unrealized gain related to our cash flow hedges are expected to be released into earnings over the next 12 months. Refer to Note 4, Fair Value Measurements, for the fair value of our derivative instruments as reported on the condensed consolidated balance sheet as of October 31, 2024 and July 31, 2024. During the three months ended October 31, 2024 and 2023, changes in the fair value of our non-designated derivative instruments recognized within other expense, net in the condensed consolidated statement of operations, were not material. The changes in accumulated other comprehensive income (loss) related to our cash flow hedges consisted of the following: Three Months Ended October 31, 2024 2023 (in thousands) Balance of AOCI as of the beginning of the period $ (4,224) $ 8,937 Net unrealized gains (losses) recognized in accumulated other comprehensive income 469 (15,136) (Gains) reclassified from AOCI into the condensed consolidated statement of operations (1) (1,208) (654) Balance of AOCI as of the end of the period $ (4,963) $ (6,853) (1) Gains related to our cash flow hedges reclassified from AOCI into the condensed consolidated statement of operations consisted of the following : Three Months Ended October 31, 2024 2023 (in thousands) Cost of revenue $ 277 $ 176 Sales and marketing 672 295 Research and development 161 92 General and administrative 98 91 Total $ 1,208 $ 654 Our derivative contracts expose us to credit risk to the extent that the counterparties may be unable to meet the terms of the underlying contracts. We mitigate this credit risk by transacting with major financial institutions with high credit ratings and standards. We periodically assess the creditworthiness of our counterparties to ensure they continue to meet our credit quality requirements. We also enter into master netting arrangements, which permit net settlement of transactions with the same counterparty. The potential impact of these rights of set-off associated with our derivative instruments was not material as of October 31, 2024 and July 31, 2024. We are not required to pledge, and are not entitled to receive, cash collateral related to these derivative instruments. We do not enter into derivative contracts for trading or speculative purposes. Interest Rate Swap Contracts During fiscal 2023, we entered into interest rate swaps contracts, maturing on July 1, 2025, designated as fair value hedges intended to hedge a portion of our fair value risk exposure due to changing interest rates by economically converting the fixed interest rate of a certain tranche of our convertible senior notes to a floating interest rate. As of October 31, 2024 and July 31, 2024 the carrying amount of the hedged convertible senior notes was $499.3 million and $498.2 million, respectively. The total notional amount of our outstanding interest rate swaps was $500.0 million as of October 31, 2024 and July 31, 2024. The gains and losses related to changes in the fair value of the interest rate swaps are included within interest expense in the condensed consolidated statement of operations and substantially offset changes in the fair value of the hedged portion of the underlying convertible senior notes that are attributable to the changes in underlying benchmark interest rates. As of October 31, 2024 and July 31, 2024, the cumulative amount of fair value hedge accounting adjustments included in the carrying amount of the convertible senior notes was $1.5 million and $4.1 million , respectively. The gains (losses) effect of derivative instruments designated as fair value hedges included within interest expense in the condensed statement of operations consisted of the following: Three Months Ended October 31, 2024 2023 (in thousands) Gains (losses) on interest rate swaps: Hedge accounting fair value adjustments $ (2,543) $ (1,110) Derivatives designated as hedging instruments 2,401 1,094 Total $ (142) $ (16)

Convertible Senior Notes

Convertible Senior Notes	3 Months Ended
	Oct. 31, 2024
Debt Disclosure [Abstract]
Convertible Senior Notes	Convertible Senior Notes On June 25, 2020, we issued $1,150.0 million in aggregate principal amount of 0.125% convertible senior notes due 2025 (the “Notes”), including the exercise in full by the initial purchasers of the Notes of their option to purchase an additional $150.0 million principal amount of the Notes. The Notes are unsecured obligations and bear interest at a rate of 0.125% per year and interest is payable semiannually in arrears on January 1 and July 1 of each year, beginning on January 1, 2021. The Notes mature on July 1, 2025, unless earlier converted, redeemed or repurchased. The total net proceeds from the offering, after deducting initial purchase discounts and other debt issuance costs, was $1,130.5 million. Refer to Note 10, Convertible Senior Notes, to the audited consolidated financial statements included in our Fiscal 2024 Form 10-K for further information on the Notes. During the three months ended October 31, 2024, the conditions allowing holders of the Notes to convert were not met. The net carrying amount of the Notes consisted of the following: October 31, July 31, 2024 2024 (in thousands) Principal amount $ 1,149,954 $ 1,149,954 Less: Unamortized debt issuance costs 2,633 3,614 Hedge accounting fair value adjustments 1,522 4,065 Total $ 1,145,799 $ 1,142,275 The interest expense related to the Notes consisted of the following: Three Months Ended October 31, 2024 2023 (in thousands) Contractual interest expense $ 359 $ 359 Amortization of debt issuance costs 981 977 Total $ 1,340 $ 1,336 The total fair value of the Notes was $1,459.8 million and $1,465.5 million as of October 31, 2024 and July 31, 2024, respectively. The fair value was determined based on the closing trading price per $1,000 of the Notes as of the last day of trading for the period. We consider the fair value of the Notes as of October 31, 2024 to be a Level II measurement as they are not actively traded. The fair value of the Notes is primarily affected by the trading price of our common stock and market interest rates. In connection with the pricing of the Notes, we entered into capped call transactions with the option counterparties (the "Capped Calls"). The Capped Calls each have an initial strike price of $150.80 per share, subject to certain adjustments, which corresponds to the initial conversion price of the Notes. The Capped Calls have an initial cap price of $246.76 per share, subject to certain adjustments. The Capped Calls are generally expected to reduce potential dilution to our common stock upon any conversion of the Notes and/or offset any cash payments we are required to make in excess of the principal amount of the converted Notes, as the case may be, with such reduction and/or offset subject to a cap. During the three months ended October 31, 2024 and 2023 , we have not exercised any Capped Call options. Refer to Note 10, Convertible Senior Notes, to the audited consolidated financial statements included in our Fiscal 2024 Form 10-K for further information on the Capped Calls.

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Oct. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Non-cancelable Purchase Obligations In the normal course of business, we enter into non-cancelable purchase commitments with various third parties to purchase products and services such as cloud infrastructure capacity, subscription-based cloud service arrangements, technology equipment, corporate and marketing events and consulting services. As of October 31, 2024, there have been no material changes outside the ordinary course of our business to our non-cancelable purchase obligations from those disclosed in the Fiscal 2024 Form 10-K, except for a non-cancelable agreement entered with a public cloud provider in September 2024 for a total minimum purchase commitment of $100.0 million over a five-year term and the renewal of bandwidth and internet service agreements for a total minimum purchase commitment of $27.1 million two Legal Matters We are a party to various litigation matters from time to time and subject to claims that arise in the ordinary course of business, including patent, commercial, product liability, employment, class action, whistleblower and other litigation and claims, as well as governmental and other regulatory investigations and proceedings. In addition, third parties may from time to time assert claims against us in the form of letters and other communications. There is no pending or threatened legal proceeding to which we are a party that, in our opinion, is likely to have a material adverse effect on our future financial results or operations; however, the results of litigation and claims are inherently unpredictable. Regardless of the outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources and other factors. The expense of litigation and the timing of this expense from period to period are difficult to estimate, subject to change and could adversely affect our results of operations.

Stock-Based Compensation

Stock-Based Compensation	3 Months Ended
	Oct. 31, 2024
Share-Based Payment Arrangement [Abstract]
Stock-Based Compensation	Stock-Based Compensation Equity Incentive Plan Equity incentive awards which may be granted to eligible participants under our Fiscal Year 2018 Equity Incentive Plan (the "2018 Plan") include restricted stock units, restricted stock, stock options, nonstatutory stock options, stock appreciation rights, performance units and performance shares. Stock Options The activity of stock options for the three months ended October 31, 2024 consisted of the following: Outstanding Weighted-Average Weighted-Average Aggregate (in thousands, except per share amounts) Balance as of July 31, 2024 453 $ 46.72 2.5 $ 60,923 Granted — $ — Exercised (87) $ 10.19 $ 14,330 Canceled, forfeited or expired — — Balance as of October 31, 2024 366 $ 55.46 2.7 $ 46,604 Exercisable and expected to vest as of July 31, 2024 367 $ 15.84 1.0 $ 59,989 Exercisable and expected to vest as of October 31, 2024 283 $ 19.11 0.9 $ 45,707 The total intrinsic value of options exercised for the three months ended October 31, 2024 and 2023 was $14.3 million and $23.2 million, respectively. There were no stock options granted during the three months ended October 31, 2024 and 2023. Restricted Stock Units and Performance Stock Awards The activity of restricted stock units ("RSUs") and performance stock awards ("PSAs") consisted of the following for the three months ended October 31, 2024: Underlying Shares Weighted-Average Grant Date Fair Value Aggregate (in thousands, except per share data) Balance as of July 31, 2024 9,814 $ 162.41 $ 1,760,079 Granted 3,197 $ 169.58 Vested (838) $ 152.78 $ 144,131 Canceled or forfeited (423) $ 167.99 Balance as of October 31, 2024 11,750 $ 164.84 $ 2,124,164 As of October 31, 2024, the number of outstanding PSAs for which the performance metrics have not been defined as of such date was not material. These awards are not considered granted for accounting purposes as of October 31, 2024 and accordingly, have been excluded from the above table. Employee Stock Purchase Plan In fiscal 2018, we adopted the Fiscal Year 2018 Employee Stock Purchase Plan (the "ESPP"). ESPP employee payroll contributions accrued as of October 31, 2024 and July 31, 2024, were $23.0 million and $8.8 million, respectively, and are included within accrued compensation in the condensed consolidated balance sheets. Payroll contributions accrued as of October 31, 2024 will be used to purchase shares at the end of the current ESPP purchase period ending on December 16, 2024. Payroll contributions ultimately used to purchase shares are reclassified to stockholders’ equity on the purchase date. There were no shares issued under the ESPP during the periods presented. Stock-based Compensation Expense The components of stock-based compensation expense recognized in the condensed consolidated statements of operations consisted of the following: Three Months Ended October 31, 2024 2023 (in thousands) Cost of revenue $ 15,226 $ 12,584 Sales and marketing 63,179 56,630 Research and development 58,071 40,193 General and administrative 20,702 19,731 Total $ 157,178 $ 129,138

Income Taxes

Income Taxes	3 Months Ended
	Oct. 31, 2024
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes Our tax provision for interim periods is determined using an estimate of our annual effective tax rate, adjusted for discrete items, if any, that arise during the period. Each quarter, we update our estimate of the annual effective tax rate, and if the estimated annual effective tax rate changes, we make a cumulative adjustment in such period. Our quarterly tax provision, and estimate of our annual effective tax rate, is subject to variation due to several factors, including variability in pre-tax income (or loss), the mix of jurisdictions to which such income relates, changes in how we do business, and tax law developments. Our estimated annual effective tax rate for the year differs from the U.S. statutory rate of 21% as a result of our U.S. losses for which no tax benefit will be realized, as well as our foreign operations which are subject to tax rates that differ from those in the United States. For the three months ended October 31, 2024 and 2023, we recorded provision for income taxes of $7.6 million a nd $9.0 million, respectively. The decrease in the tax expense for three months ended October 31, 2024 is primarily attributable to tax expense associated with the integration of a business acquisition in the three months ended October 31, 2023. We are subject to income tax in the United States as well as other tax jurisdictions in which we conduct business. Earnings from our non-U.S. operations are subject to income taxes in the countries in which we operate. The realization of deferred tax assets is dependent upon the generation of sufficient taxable income of the appropriate character in future periods. We assess our ability to realize the deferred tax assets on a quarterly basis and we establish a valuation allowance if it is more-likely-than-not that some portion of the deferred tax assets will not be realized. We weigh all available positive and negative evidence, including our earnings history and results of recent operations, scheduled reversals of deferred tax liabilities, projected future taxable income and tax planning strategies. Due to the weight of objectively verifiable negative evidence, including our history of losses in certain jurisdictions, we believe that it is more likely than not that our U.S. federal, state and foreign jurisdictions deferred tax assets will not be realized. Accordingly, we have maintained a valuation allowance on our U.S. federal, state and certain foreign jurisdiction deferred tax assets. Continued performance improvement in the United Kingdom ("U.K.") could result in a change in the realization of the deferred tax assets in the next twelve months, which would result in a release of the valuation allowance for such jurisdiction. A change in our assessment as to the realizability of the U.K. deferred tax assets is dependent upon the existence of sufficient objectively verifiable positive evidence in future periods. The reversal of such valuation allowance would result in an income tax benefit for the quarterly and annual fiscal periods in which we release the valuation allowance. However, the exact timing and amount of the valuation allowance release are subject to change on the basis of the positive evidence that exists at such time.

Net Loss Per Share

Net Loss Per Share	3 Months Ended
	Oct. 31, 2024
Earnings Per Share [Abstract]
Net Loss Per Share	Net Loss Per Share The computation of basic and diluted net loss per share consisted of the following: Three Months Ended October 31, 2024 2023 (in thousands, except per share data) Net loss $ (12,051) $ (33,483) Weighted-average shares used in computing net loss per share, basic and diluted 152,557 147,625 Net loss per share, basic and diluted $ (0.08) $ (0.23) Since we have reported net losses for all periods presented, we have excluded all potentially dilutive securities from the calculation of the diluted net loss per share as their effect is antidilutive and accordingly, the basic and diluted net loss per share is the same for all periods presented. In connection with the issuance of the Notes, we entered into Capped Calls, which were not included for purposes of calculating the number of diluted shares outstanding, as their effect would have been anti-dilutive. The Capped Calls are expected to partially offset the potential dilution to our common stock upon any conversion of the Notes. We have not exercised any of the Capped Calls as of October 31, 2024. The following table summarizes the outstanding potentially dilutive securities that were excluded from the computation of diluted net loss per share as their effect would be antidilutive: October 31, 2024 2023 (in thousands) Unvested RSUs and shares of common stock 11,184 9,467 Stock options 366 1,116 Unvested PSAs (1) 947 867 Share purchase rights under the ESPP 496 1,065 Notes (2) 7,626 7,626 Total 20,619 20,141 (1) The number of unvested PSAs is estimated at 100% of the target number of shares granted and excludes unvested PSAs for which performance conditions have not been established as of October 31, 2024 and 2023, as they are not considered outstanding for accounting purposes. For further information refer to Note 11, Stock-Based Compensation. (2) The shares underlying the conversion option in the Notes were not considered in the calculation of diluted net loss per share for all the periods presented, as their effect would have been antidilutive. Based on the initial conversion price, the entire outstanding principal amount of the Notes as of October 31, 2024 would have been convertible into approximately 7.6 million shares of our common stock, which is reflected in the above table. Conversion notices received through October 31, 2024 have not been material.

Subsequent Events

Subsequent Events	3 Months Ended
	Oct. 31, 2024
Subsequent Events [Abstract]
Subsequent Events	Subsequent Events In November 2024, we entered into a non-cancelable agreement with a public cloud provider for a total minimum purchase commitment of $300.0 million over a five-year term.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended
	Oct. 31, 2024	Oct. 31, 2023
Pay vs Performance Disclosure
Net loss	$ (12,051)	$ (33,483)

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Oct. 31, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Business and Summary of Signi_2

Business and Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Oct. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States ("GAAP") and applicable regulations of the Securities and Exchange Commission ("SEC") regarding interim financial reporting, and include the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to the applicable required disclosures and regulations of the SEC. Therefore, these unaudited condensed consolidated financial statements and accompanying notes should be read in conjunction with the Company's audited consolidated financial statements and related notes in its Annual Report on Form 10-K for the fiscal year ended July 31, 2024 (the "Fiscal 2024 Form 10-K"), as filed with the SEC on September 12, 2024.
Use of Estimates	Use of Estimates The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates, judgments and assumptions that affect the amounts reported and disclosed in the financial statements and accompanying notes. Such estimates include, but are not limited to, the determination of revenue recognition, deferred revenue, deferred contract acquisition costs, capitalized internal-use software, valuation of acquired intangible assets, period of benefit generated from our deferred contract acquisition costs, allowance for doubtful accounts, valuation of common stock options and stock-based awards, useful lives of property and equipment, useful lives of acquired intangible assets, recoverability of goodwill, valuation of deferred tax assets and liabilities, loss contingencies related to litigation, fair value of convertible senior notes and the discount rate used for operating leases. Management determines these estimates and assumptions based on historical experience and on various other assumptions that are believed to be reasonable. Actual results could differ significantly from these estimates, and such differences may be material to the condensed consolidated financial statements. Due to uncertainty in the macroeconomic and geopolitical environment, there is ongoing disruption in the global economy and financial markets. We are not aware of any specific event or circumstances that would require an update to our estimates, judgments or assumptions or a revision to the carrying value of our assets or liabilities as of the date of issuance of these condensed consolidated financial statements. These estimates, judgments and assumptions may change in the future, as new events occur or additional information is obtained .
Fiscal Year	Fiscal Year Our fiscal year ends on July 31. References to fiscal 2025, for example, refer to our fiscal year ending July 31, 2025.
Recently Issued Accounting Pronouncements Not Yet Adopted	Recently Issued Accounting Pronouncements Not Yet Adopted In November 2023, the Financial Accounting Standards Board ("FASB") issued ASU No. 2023-07, Segment Reporting (Topic 280 ): Improvements to Reportable Segment Disclosures , which requires disclosure of incremental segment information on an annual and interim basis. Th is standard is effective for us in the annual periods beginning in fiscal 2025 and interim periods beginning in the first quarter of fiscal 2026. We are currently evaluating the potential impact of this standard on our consolidated financial statement disclosures. In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. The amended guidance enhances income tax disclosures primarily related to the effective tax rate reconciliation and income taxes paid information. This standard requires disclosures of specific categories in the effective tax rate reconciliation and further information on reconciling items meeting a quantitative threshold. In addition, the amended guidance requires disaggregating income taxes paid (net of refunds received) by federal, state and foreign taxes. It also requires disaggregating individual jurisdictions in which income taxes paid (net of refunds received) is equal to or greater than 5% of total income taxes paid (net of refunds received). This standard is effective for us in the annual periods beginning in fiscal 2026 . We are currently evaluating the potential impact of this standard on our consolidated financial statement disclosures. In November 2024, the FASB issued ASU No. 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40), Disaggregation of Income Statement Expenses . This standard requires disclosures of additional information about specific expense categories in the notes to the financial statements for interim and annual reporting periods . This standard is effective for us in the annual periods beginning in fiscal 2028 and interim periods beginning in the first quarter of fiscal 2029. We are currently evaluating the potential impact of this standard on our consolidated financial statement disclosures.

Revenue Recognition (Tables)

Revenue Recognition (Tables)	3 Months Ended
	Oct. 31, 2024
Revenue from Contract with Customer [Abstract]
Schedule of Disaggregation of Revenue	The following table summarizes the revenue by region based on the shipping address of customers who have contracted to use our cloud platform: Three Months Ended October 31, 2024 2023 Amount % Revenue Amount % Revenue (in thousands, except for percentage data) United States $ 319,312 51 % $ 247,531 50 % Europe, Middle East and Africa 186,069 30 % 157,245 32 % Asia Pacific 99,382 16 % 75,080 15 % Other 23,192 3 % 16,847 3 % Total $ 627,955 100 % $ 496,703 100 % The following table summarizes the revenue from contracts by type of customer: Three Months Ended October 31, 2024 2023 Amount % Revenue Amount % Revenue (in thousands, except for percentage data) Channel partners $ 558,360 89 % $ 454,456 91 % Direct customers 69,595 11 % 42,247 9 % Total $ 627,955 100 % $ 496,703 100 %
Schedules of Accounts Receivable	The following table summarizes the concentration of 10% or more of the total balance of accounts receivable, net: October 31, 2024 July 31, 2024 Channel partner A 11% * (*) Represents less than 10%.
Schedule of Capitalized Contract Cost	The activity of the deferred contract acquisition costs consisted of the following: Three Months Ended October 31, 2024 2023 (in thousands) Beginning balance $ 445,398 $ 375,234 Capitalization of contract acquisition costs 32,801 27,680 Amortization of deferred contract acquisition costs (39,068) (30,111) Ending balance $ 439,131 $ 372,803 The outstanding balance of the deferred contract acquisition costs consisted of the following: October 31, 2024 July 31, 2024 (in thousands) Deferred contract acquisition costs, current $ 152,475 $ 148,873 Deferred contract acquisition costs, noncurrent 286,656 296,525 Total deferred contract acquisition costs $ 439,131 $ 445,398

Cash Equivalents and Short-Te_2

Cash Equivalents and Short-Term Investments (Tables)	3 Months Ended
	Oct. 31, 2024
Cash and Cash Equivalents [Abstract]
Schedule of Cash Equivalents and Short-Term Investments	Cash equivalents and short-term investments consisted of the following as of October 31, 2024: Amortized Unrealized Unrealized Fair Value Cash equivalents: (in thousands) Money market funds $ 1,172,163 $ — $ — $ 1,172,163 U.S. treasury securities 35,898 5 — 35,903 U.S. government agency securities 107,255 3 (19) 107,239 Certificates of deposit 106,452 — — 106,452 Total cash equivalents $ 1,421,768 $ 8 $ (19) $ 1,421,757 Short-term investments: U.S. treasury securities $ 314,332 $ 59 $ (436) $ 313,955 U.S. government agency securities 183,431 92 (195) 183,328 Corporate debt securities 655,888 2,164 (1,083) 656,969 Total short-term investments $ 1,153,651 $ 2,315 $ (1,714) $ 1,154,252 Total cash equivalents and short-term investments $ 2,575,419 $ 2,323 $ (1,733) $ 2,576,009 Cash equivalents and short-term investments consisted of the following as of July 31, 2024: Amortized Unrealized Unrealized Fair Value Cash equivalents: (in thousands) Money market funds $ 956,932 $ — $ — $ 956,932 U.S. treasury securities 178,188 — (15) 178,173 U.S. government agency securities 57,555 — (6) 57,549 Certificates of deposit 80,940 — — 80,940 Total cash equivalents $ 1,273,615 $ — $ (21) $ 1,273,594 Short-term investments: U.S. treasury securities $ 257,841 $ 8 $ (828) $ 257,021 U.S. government agency securities 160,574 43 (542) 160,075 Corporate debt securities 568,589 1,514 (625) 569,478 Total short-term investments $ 987,004 $ 1,565 $ (1,995) $ 986,574 Total cash equivalents and short-term investments $ 2,260,619 $ 1,565 $ (2,016) $ 2,260,168
Schedule of Maturities	The amortized cost and fair value of our short-term investments based on their stated maturities consisted of the following as of October 31, 2024: Amortized Fair Value (in thousands) Due within one year $ 562,736 $ 562,907 Due between one to three years 590,915 591,345 Total $ 1,153,651 $ 1,154,252
Schedule of Unrealized Loss on Investments	Short-term investments that were in continuous unrealized loss position as of October 31, 2024 consisted of the following: Less than 12 Months Greater than 12 Months Total Fair Unrealized Fair Unrealized Fair Unrealized (in thousands) U.S. treasury securities $ 146,042 $ (436) $ — $ — $ 146,042 $ (436) U.S. government agency securities 127,374 (174) 11,096 (21) 138,470 (195) Corporate debt securities 166,536 (1,050) 25,384 (33) 191,920 (1,083) Total $ 439,952 $ (1,660) $ 36,480 $ (54) $ 476,432 $ (1,714) Short-term investments that were in continuous unrealized loss position as of July 31, 2024 consisted of the following: Less than 12 Months Greater than 12 Months Total Fair Unrealized Fair Unrealized Fair Unrealized (in thousands) U.S. treasury securities $ 152,574 $ (115) $ 87,808 $ (713) $ 240,382 $ (828) U.S. government agency securities 65,563 (28) 65,334 (514) 130,897 (542) Corporate debt securities 81,020 (102) 94,666 (523) 175,686 (625) Total $ 299,157 $ (245) $ 247,808 $ (1,750) $ 546,965 $ (1,995)

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	3 Months Ended
	Oct. 31, 2024
Fair Value Disclosures [Abstract]
Schedule of Fair Value, Assets Measured on Recurring Basis	Assets and liabilities that are measured at fair value on a recurring basis consisted of the following as of October 31, 2024: Level I Level II Level III Fair Value Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs Cash equivalents: (in thousands) Money market funds $ 1,172,163 $ 1,172,163 $ — $ — U.S. treasury securities 35,903 — 35,903 — U.S. government agency securities 107,239 — 107,239 — Certificates of deposit 106,452 — 106,452 — Total cash equivalents $ 1,421,757 $ 1,172,163 $ 249,594 $ — Short-term investments: U.S. treasury securities $ 313,955 $ — $ 313,955 $ — U.S. government agency securities 183,328 — 183,328 — Corporate debt securities 656,969 — 656,969 — Total short-term investments $ 1,154,252 $ — $ 1,154,252 $ — Total cash equivalents and short-term investments $ 2,576,009 $ 1,172,163 $ 1,403,846 $ — Designated derivative instruments: Foreign currency contracts assets-current (1) $ 2,918 $ — $ 2,918 $ — Foreign currency contracts assets-noncurrent (2) $ 665 $ — $ 665 $ — Foreign currency contracts liabilities-current (3) $ 4,720 $ — $ 4,720 $ — Foreign currency contracts liabilities-noncurrent (4) $ 1,201 $ — $ 1,201 $ — Interest rate contracts liabilities-current (3) $ 1,428 $ — $ 1,428 $ — Non-designated derivative instruments: Foreign currency contracts assets-current (1) $ 745 $ — $ 745 $ — Foreign currency contracts liabilities-current (3) $ 3,492 $ — $ 3,492 $ — (1) Included within prepaid expenses and other current assets in the condensed consolidated balance sheets. (2) Included within other noncurrent assets in the condensed consolidated balance sheets. (3) Included within accrued expenses and other current liabilities in the condensed consolidated balance sheets. (4) Included within other noncurrent liabilities in the condensed consolidated balance sheets. Assets that are measured at fair value on a recurring basis consisted of the following as of July 31, 2024: Level I Level II Level III Fair Value Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs Cash equivalents: (in thousands) Money market funds $ 956,932 $ 956,932 $ — $ — U.S. treasury securities 178,173 — 178,173 — U.S. government agency securities 57,549 — 57,549 — Certificates of deposit 80,940 — 80,940 — Total cash equivalents $ 1,273,594 $ 956,932 $ 316,662 $ — Short-term investments: U.S. treasury securities $ 257,021 $ — $ 257,021 $ — U.S. government agency securities 160,075 — 160,075 — Corporate debt securities 569,478 — 569,478 — Total short-term investments $ 986,574 $ — $ 986,574 $ — Total cash equivalents and short-term investments $ 2,260,168 $ 956,932 $ 1,303,236 $ — Designated derivative instruments: Foreign currency contracts assets-current (1) $ 2,541 $ — $ 2,541 $ — Foreign currency contract assets-noncurrent (2) $ 800 $ — $ 800 $ — Foreign currency contracts liabilities-current (3) $ 3,731 $ — $ 3,731 $ — Foreign currency contracts liabilities-noncurrent (4) $ 844 $ — $ 844 $ — Interest rate contracts liabilities-current (3) $ 3,829 $ — $ 3,829 $ — Non-designated derivative instruments: Foreign currency contracts assets-current (1) $ 2,132 $ — $ 2,132 $ — Foreign currency contracts liabilities-current (3) $ 1,748 $ — $ 1,748 $ — (1) Included within prepaid expenses and other current assets in the consolidated balance sheets. (2) Included within other noncurrent assets in the consolidated balance sheets. (3) Included within accrued expenses and other current liabilities in the consolidated balance sheets. (4) Included within other noncurrent liabilities in the consolidated balance sheets.
Schedule of Fair Value, Liabilities Measured on Recurring Basis	Assets and liabilities that are measured at fair value on a recurring basis consisted of the following as of October 31, 2024: Level I Level II Level III Fair Value Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs Cash equivalents: (in thousands) Money market funds $ 1,172,163 $ 1,172,163 $ — $ — U.S. treasury securities 35,903 — 35,903 — U.S. government agency securities 107,239 — 107,239 — Certificates of deposit 106,452 — 106,452 — Total cash equivalents $ 1,421,757 $ 1,172,163 $ 249,594 $ — Short-term investments: U.S. treasury securities $ 313,955 $ — $ 313,955 $ — U.S. government agency securities 183,328 — 183,328 — Corporate debt securities 656,969 — 656,969 — Total short-term investments $ 1,154,252 $ — $ 1,154,252 $ — Total cash equivalents and short-term investments $ 2,576,009 $ 1,172,163 $ 1,403,846 $ — Designated derivative instruments: Foreign currency contracts assets-current (1) $ 2,918 $ — $ 2,918 $ — Foreign currency contracts assets-noncurrent (2) $ 665 $ — $ 665 $ — Foreign currency contracts liabilities-current (3) $ 4,720 $ — $ 4,720 $ — Foreign currency contracts liabilities-noncurrent (4) $ 1,201 $ — $ 1,201 $ — Interest rate contracts liabilities-current (3) $ 1,428 $ — $ 1,428 $ — Non-designated derivative instruments: Foreign currency contracts assets-current (1) $ 745 $ — $ 745 $ — Foreign currency contracts liabilities-current (3) $ 3,492 $ — $ 3,492 $ — (1) Included within prepaid expenses and other current assets in the condensed consolidated balance sheets. (2) Included within other noncurrent assets in the condensed consolidated balance sheets. (3) Included within accrued expenses and other current liabilities in the condensed consolidated balance sheets. (4) Included within other noncurrent liabilities in the condensed consolidated balance sheets. Assets that are measured at fair value on a recurring basis consisted of the following as of July 31, 2024: Level I Level II Level III Fair Value Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs Cash equivalents: (in thousands) Money market funds $ 956,932 $ 956,932 $ — $ — U.S. treasury securities 178,173 — 178,173 — U.S. government agency securities 57,549 — 57,549 — Certificates of deposit 80,940 — 80,940 — Total cash equivalents $ 1,273,594 $ 956,932 $ 316,662 $ — Short-term investments: U.S. treasury securities $ 257,021 $ — $ 257,021 $ — U.S. government agency securities 160,075 — 160,075 — Corporate debt securities 569,478 — 569,478 — Total short-term investments $ 986,574 $ — $ 986,574 $ — Total cash equivalents and short-term investments $ 2,260,168 $ 956,932 $ 1,303,236 $ — Designated derivative instruments: Foreign currency contracts assets-current (1) $ 2,541 $ — $ 2,541 $ — Foreign currency contract assets-noncurrent (2) $ 800 $ — $ 800 $ — Foreign currency contracts liabilities-current (3) $ 3,731 $ — $ 3,731 $ — Foreign currency contracts liabilities-noncurrent (4) $ 844 $ — $ 844 $ — Interest rate contracts liabilities-current (3) $ 3,829 $ — $ 3,829 $ — Non-designated derivative instruments: Foreign currency contracts assets-current (1) $ 2,132 $ — $ 2,132 $ — Foreign currency contracts liabilities-current (3) $ 1,748 $ — $ 1,748 $ — (1) Included within prepaid expenses and other current assets in the consolidated balance sheets. (2) Included within other noncurrent assets in the consolidated balance sheets. (3) Included within accrued expenses and other current liabilities in the consolidated balance sheets. (4) Included within other noncurrent liabilities in the consolidated balance sheets.

Balance Sheet Components (Table

Balance Sheet Components (Tables)	3 Months Ended
	Oct. 31, 2024
Property, Plant and Equipment [Abstract]
Schedule of Property and Equipment	Property and equipment consisted of the following: October 31, 2024 July 31, 2024 (in thousands) Hosting equipment $ 434,018 $ 418,775 Capitalized internal-use software 232,092 197,769 Computers and equipment 7,081 6,741 Purchased software 1,103 1,102 Furniture and fixtures 1,077 1,071 Leasehold improvements 8,341 7,974 Total property and equipment, gross 683,712 633,432 Less: Accumulated depreciation and amortization (274,707) (250,311) Total property and equipment, net $ 409,005 $ 383,121
Summary Of Accrued Compensation	Accrued compensation consisted of the following: October 31, 2024 July 31, 2024 (in thousands) Accrued commissions $ 22,045 $ 51,371 Accrued bonuses 33,372 53,452 Accrued payroll and related expenses 47,924 47,184 Employee stock purchase plan 23,038 8,803 Total accrued compensation $ 126,379 $ 160,810

Goodwill and Acquired Intangi_2

Goodwill and Acquired Intangible Assets (Tables)	3 Months Ended
	Oct. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Acquired Intangible Assets	Changes in acquired intangible assets for the three months ended October 31, 2024 consisted of the following: Gross Carrying Amount Accumulated Amortization Net Carrying Amount Weighted Average Remaining Useful life July 31, 2024 Additions October 31, 2024 July 31, 2024 Amortization Expense October 31, 2024 July 31, 2024 October 31, 2024 October 31, 2024 (in thousands) (years) Developed technology $ 99,656 $ — $ 99,656 $ (42,651) $ (3,815) $ (46,466) $ 57,005 $ 53,190 4.0 Customer relationships 9,960 — 9,960 (3,130) (425) (3,555) 6,830 6,405 4.1 Total $ 109,616 $ — $ 109,616 $ (45,781) $ (4,240) $ (50,021) $ 63,835 $ 59,595 4.0
Schedule of Future Amortization Expense	Future amortization expense of acquired intangible assets as of October 31, 2024 consists of the following: Amount Fiscal Year ending July 31, (in thousands) 2025 (remaining nine months) $ 12,545 2026 15,772 2027 12,948 2028 11,115 2029 7,215 Total $ 59,595

Derivative Instruments (Tables)

Derivative Instruments (Tables)	3 Months Ended
	Oct. 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Changes of AOCI Related to our Cash Flow Hedges and Cash Flow Hedges on our Consolidated Statement of Operations	The changes in accumulated other comprehensive income (loss) related to our cash flow hedges consisted of the following: Three Months Ended October 31, 2024 2023 (in thousands) Balance of AOCI as of the beginning of the period $ (4,224) $ 8,937 Net unrealized gains (losses) recognized in accumulated other comprehensive income 469 (15,136) (Gains) reclassified from AOCI into the condensed consolidated statement of operations (1) (1,208) (654) Balance of AOCI as of the end of the period $ (4,963) $ (6,853) (1) Gains related to our cash flow hedges reclassified from AOCI into the condensed consolidated statement of operations consisted of the following : Three Months Ended October 31, 2024 2023 (in thousands) Cost of revenue $ 277 $ 176 Sales and marketing 672 295 Research and development 161 92 General and administrative 98 91 Total $ 1,208 $ 654
Schedule of Derivative Instruments Designated as Fair Value Hedges	The gains (losses) effect of derivative instruments designated as fair value hedges included within interest expense in the condensed statement of operations consisted of the following: Three Months Ended October 31, 2024 2023 (in thousands) Gains (losses) on interest rate swaps: Hedge accounting fair value adjustments $ (2,543) $ (1,110) Derivatives designated as hedging instruments 2,401 1,094 Total $ (142) $ (16)

Convertible Senior Notes (Table

Convertible Senior Notes (Tables)	3 Months Ended
	Oct. 31, 2024
Debt Disclosure [Abstract]
Schedule of Convertible Senior Notes	The net carrying amount of the Notes consisted of the following: October 31, July 31, 2024 2024 (in thousands) Principal amount $ 1,149,954 $ 1,149,954 Less: Unamortized debt issuance costs 2,633 3,614 Hedge accounting fair value adjustments 1,522 4,065 Total $ 1,145,799 $ 1,142,275 The interest expense related to the Notes consisted of the following: Three Months Ended October 31, 2024 2023 (in thousands) Contractual interest expense $ 359 $ 359 Amortization of debt issuance costs 981 977 Total $ 1,340 $ 1,336

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	3 Months Ended
	Oct. 31, 2024
Share-Based Payment Arrangement [Abstract]
Schedule of Stock Options	The activity of stock options for the three months ended October 31, 2024 consisted of the following: Outstanding Weighted-Average Weighted-Average Aggregate (in thousands, except per share amounts) Balance as of July 31, 2024 453 $ 46.72 2.5 $ 60,923 Granted — $ — Exercised (87) $ 10.19 $ 14,330 Canceled, forfeited or expired — — Balance as of October 31, 2024 366 $ 55.46 2.7 $ 46,604 Exercisable and expected to vest as of July 31, 2024 367 $ 15.84 1.0 $ 59,989 Exercisable and expected to vest as of October 31, 2024 283 $ 19.11 0.9 $ 45,707
Schedule of Restricted Stock Units and Performance Stock Awards Activity	The activity of restricted stock units ("RSUs") and performance stock awards ("PSAs") consisted of the following for the three months ended October 31, 2024: Underlying Shares Weighted-Average Grant Date Fair Value Aggregate (in thousands, except per share data) Balance as of July 31, 2024 9,814 $ 162.41 $ 1,760,079 Granted 3,197 $ 169.58 Vested (838) $ 152.78 $ 144,131 Canceled or forfeited (423) $ 167.99 Balance as of October 31, 2024 11,750 $ 164.84 $ 2,124,164
Schedule of Allocation of Stock-based Compensation Expense	The components of stock-based compensation expense recognized in the condensed consolidated statements of operations consisted of the following: Three Months Ended October 31, 2024 2023 (in thousands) Cost of revenue $ 15,226 $ 12,584 Sales and marketing 63,179 56,630 Research and development 58,071 40,193 General and administrative 20,702 19,731 Total $ 157,178 $ 129,138

Net Loss Per Share (Tables)

Net Loss Per Share (Tables)	3 Months Ended
	Oct. 31, 2024
Earnings Per Share [Abstract]
Schedule of Net Loss Per Share, Basic and Diluted	The computation of basic and diluted net loss per share consisted of the following: Three Months Ended October 31, 2024 2023 (in thousands, except per share data) Net loss $ (12,051) $ (33,483) Weighted-average shares used in computing net loss per share, basic and diluted 152,557 147,625 Net loss per share, basic and diluted $ (0.08) $ (0.23)
Schedule of Antidilutive Securities Excluded from Computation of Net Loss Per Share	The following table summarizes the outstanding potentially dilutive securities that were excluded from the computation of diluted net loss per share as their effect would be antidilutive: October 31, 2024 2023 (in thousands) Unvested RSUs and shares of common stock 11,184 9,467 Stock options 366 1,116 Unvested PSAs (1) 947 867 Share purchase rights under the ESPP 496 1,065 Notes (2) 7,626 7,626 Total 20,619 20,141 (1) The number of unvested PSAs is estimated at 100% of the target number of shares granted and excludes unvested PSAs for which performance conditions have not been established as of October 31, 2024 and 2023, as they are not considered outstanding for accounting purposes. For further information refer to Note 11, Stock-Based Compensation. (2) The shares underlying the conversion option in the Notes were not considered in the calculation of diluted net loss per share for all the periods presented, as their effect would have been antidilutive. Based on the initial conversion price, the entire outstanding principal amount of the Notes as of October 31, 2024 would have been convertible into approximately 7.6 million shares of our common stock, which is reflected in the above table. Conversion notices received through October 31, 2024 have not been material.

Revenue Recognition - Narrative

Revenue Recognition - Narrative (Details) - USD ($) $ in Millions	3 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Jul. 31, 2024
Concentration Risk [Line Items]
Deferred revenue	$ 1,783.7		$ 1,895
Contract with customer, liability, revenue recognized	595.2	$ 462.9
Revenue, remaining performance obligation	$ 4,410.6
Minimum
Concentration Risk [Line Items]
Contract with customer, term of contract	1 year
Maximum
Concentration Risk [Line Items]
Contract with customer, term of contract	3 years
Transferred Over Time | Product Concentration Risk | Subscription and Support | Revenue Benchmark
Concentration Risk [Line Items]
Concentration risk percentage	97%	97%

Revenue Recognition - Disaggreg

Revenue Recognition - Disaggregation of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended
	Oct. 31, 2024	Oct. 31, 2023
Disaggregation of Revenue [Line Items]
Revenue	$ 627,955	$ 496,703
Revenue Benchmark | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Revenue	$ 627,955	$ 496,703
Revenue percentage	100%	100%
Revenue Benchmark | Customer Concentration Risk
Disaggregation of Revenue [Line Items]
Revenue	$ 627,955	$ 496,703
Revenue percentage	100%	100%
Revenue Benchmark | Customer Concentration Risk | Channel partners
Disaggregation of Revenue [Line Items]
Revenue	$ 558,360	$ 454,456
Revenue percentage	89%	91%
Revenue Benchmark | Customer Concentration Risk | Direct customers
Disaggregation of Revenue [Line Items]
Revenue	$ 69,595	$ 42,247
Revenue percentage	11%	9%
United States | Revenue Benchmark | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Revenue	$ 319,312	$ 247,531
Revenue percentage	51%	50%
Europe, Middle East and Africa | Revenue Benchmark | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Revenue	$ 186,069	$ 157,245
Revenue percentage	30%	32%
Asia Pacific | Revenue Benchmark | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Revenue	$ 99,382	$ 75,080
Revenue percentage	16%	15%
Other | Revenue Benchmark | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Revenue	$ 23,192	$ 16,847
Revenue percentage	3%	3%

Revenue Recognition - Accounts

Revenue Recognition - Accounts Receivable (Details)	3 Months Ended
	Oct. 31, 2024
Customer Concentration Risk | Channel Partner A | Accounts Receivable
Concentration Risk [Line Items]
Concentration risk percentage	11%

Revenue Recognition - Performan

Revenue Recognition - Performance Obligation (Details)	Oct. 31, 2024
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-11-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, percentage	49%
Recognized transaction price period	12 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-11-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, percentage	93%
Recognized transaction price period	3 years

Revenue Recognition - Capitaliz

Revenue Recognition - Capitalized Contract Costs (Details) - USD ($) $ in Thousands	3 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Jul. 31, 2024
Changes in Capitalized Contract Cost [Roll Forward]
Beginning balance	$ 445,398	$ 375,234
Capitalization of contract acquisition costs	32,801	27,680
Amortization of deferred contract acquisition costs	(39,068)	(30,111)
Ending balance	439,131	372,803
Deferred contract acquisition costs, current	152,475		$ 148,873
Deferred contract acquisition costs, noncurrent	286,656		296,525
Total deferred contract acquisition costs	$ 439,131	$ 372,803	$ 445,398

Cash Equivalents and Short-Te_3

Cash Equivalents and Short-Term Investments - Schedule of Cash Equivalents and Short-term Investments (Details) - USD ($) $ in Thousands	Oct. 31, 2024	Jul. 31, 2024
Cash equivalents:
Amortized Cost	$ 1,421,768	$ 1,273,615
Unrealized Gains	8	0
Unrealized Losses	(19)	(21)
Fair Value	1,421,757	1,273,594
Short-term investments:
Amortized Cost	1,153,651	987,004
Unrealized Gains	2,315	1,565
Unrealized Losses	(1,714)	(1,995)
Fair Value	1,154,252	986,574
Total cash equivalents and short-term investments, amortized cost	2,575,419	2,260,619
Total cash equivalents and short-term investments, unrealized gains	2,323	1,565
Total cash equivalents and short-term investments, unrealized losses	(1,733)	(2,016)
Total cash equivalents and short-term investments	2,576,009	2,260,168
U.S. treasury securities
Short-term investments:
Amortized Cost	314,332	257,841
Unrealized Gains	59	8
Unrealized Losses	(436)	(828)
Fair Value	313,955	257,021
U.S. government agency securities
Short-term investments:
Amortized Cost	183,431	160,574
Unrealized Gains	92	43
Unrealized Losses	(195)	(542)
Fair Value	183,328	160,075
Corporate debt securities
Short-term investments:
Amortized Cost	655,888	568,589
Unrealized Gains	2,164	1,514
Unrealized Losses	(1,083)	(625)
Fair Value	656,969	569,478
Money market funds
Cash equivalents:
Amortized Cost	1,172,163	956,932
Unrealized Gains	0	0
Unrealized Losses	0	0
Fair Value	1,172,163	956,932
U.S. treasury securities
Cash equivalents:
Amortized Cost	35,898	178,188
Unrealized Gains	5	0
Unrealized Losses	0	(15)
Fair Value	35,903	178,173
U.S. government agency securities
Cash equivalents:
Amortized Cost	107,255	57,555
Unrealized Gains	3	0
Unrealized Losses	(19)	(6)
Fair Value	107,239	57,549
Certificates of deposit
Cash equivalents:
Amortized Cost	106,452	80,940
Unrealized Gains	0	0
Unrealized Losses	0	0
Fair Value	$ 106,452	$ 80,940

Cash Equivalents and Short-Te_4

Cash Equivalents and Short-Term Investments - Schedule of Maturities (Details) - USD ($) $ in Thousands	Oct. 31, 2024	Jul. 31, 2024
Amortized Cost
Due within one year	$ 562,736
Due between one to three years	590,915
Amortized Cost	1,153,651	$ 987,004
Fair Value
Due within one year	562,907
Due between one to three years	591,345
Fair Value	$ 1,154,252	$ 986,574

Cash Equivalents and Short-Te_5

Cash Equivalents and Short-Term Investments - Schedule of Unrealized Position (Details) - USD ($) $ in Thousands	Oct. 31, 2024	Jul. 31, 2024
Debt Securities, Available-for-sale [Line Items]
Less than 12 months, fair value	$ 439,952	$ 299,157
Less than 12 months, unrealized losses	(1,660)	(245)
Greater than 12 months, fair value	36,480	247,808
Greater than 12 months, unrealized losses	(54)	(1,750)
Total fair value	476,432	546,965
Total unrealized losses	(1,714)	(1,995)
U.S. treasury securities
Debt Securities, Available-for-sale [Line Items]
Less than 12 months, fair value	146,042	152,574
Less than 12 months, unrealized losses	(436)	(115)
Greater than 12 months, fair value	0	87,808
Greater than 12 months, unrealized losses	0	(713)
Total fair value	146,042	240,382
Total unrealized losses	(436)	(828)
U.S. government agency securities
Debt Securities, Available-for-sale [Line Items]
Less than 12 months, fair value	127,374	65,563
Less than 12 months, unrealized losses	(174)	(28)
Greater than 12 months, fair value	11,096	65,334
Greater than 12 months, unrealized losses	(21)	(514)
Total fair value	138,470	130,897
Total unrealized losses	(195)	(542)
Corporate debt securities
Debt Securities, Available-for-sale [Line Items]
Less than 12 months, fair value	166,536	81,020
Less than 12 months, unrealized losses	(1,050)	(102)
Greater than 12 months, fair value	25,384	94,666
Greater than 12 months, unrealized losses	(33)	(523)
Total fair value	191,920	175,686
Total unrealized losses	$ (1,083)	$ (625)

Cash Equivalents and Short-Te_6

Cash Equivalents and Short-Term Investments - Narrative (Details) - USD ($) $ in Millions	Oct. 31, 2024	Jul. 31, 2024
Cash and Cash Equivalents [Abstract]
Accrued interest receivable	$ 12.6	$ 10.7
Investment carrying value	$ 10.3	$ 9.8

Fair Value Measurements (Detail

Fair Value Measurements (Details) - USD ($) $ in Thousands	Oct. 31, 2024	Jul. 31, 2024
Cash equivalents:
Cash equivalents	$ 1,421,757	$ 1,273,594
Short-term investments:
Short-term investments	1,154,252	986,574
Total cash equivalents and short-term investments	2,576,009	2,260,168
Fair Value, Measurements, Recurring
Cash equivalents:
Cash equivalents	1,421,757	1,273,594
Short-term investments:
Short-term investments	1,154,252	986,574
Total cash equivalents and short-term investments	2,576,009	2,260,168
Fair Value, Measurements, Recurring | Foreign currency contracts | Designated as Hedging Instrument
Designated derivative instruments:
Foreign currency contracts assets-current	2,918	2,541
Foreign currency contract assets-noncurrent	665	800
Foreign currency contracts liabilities-current	4,720	3,731
Foreign currency contracts liabilities-noncurrent	1,201	844
Non-designated derivative instruments:
Foreign currency contracts assets-current	2,918	2,541
Foreign currency contracts liabilities-current	4,720	3,731
Fair Value, Measurements, Recurring | Foreign currency contracts | Not Designated as Hedging Instrument
Designated derivative instruments:
Foreign currency contracts assets-current	745	2,132
Foreign currency contracts liabilities-current	3,492	1,748
Non-designated derivative instruments:
Foreign currency contracts assets-current	745	2,132
Foreign currency contracts liabilities-current	3,492	1,748
Fair Value, Measurements, Recurring | Interest rate contracts | Designated as Hedging Instrument
Designated derivative instruments:
Foreign currency contracts liabilities-current	1,428	3,829
Non-designated derivative instruments:
Foreign currency contracts liabilities-current	1,428	3,829
Fair Value, Measurements, Recurring | Level I
Cash equivalents:
Cash equivalents	1,172,163	956,932
Short-term investments:
Short-term investments	0	0
Total cash equivalents and short-term investments	1,172,163	956,932
Fair Value, Measurements, Recurring | Level I | Foreign currency contracts | Designated as Hedging Instrument
Designated derivative instruments:
Foreign currency contracts assets-current	0	0
Foreign currency contract assets-noncurrent	0	0
Foreign currency contracts liabilities-current	0	0
Foreign currency contracts liabilities-noncurrent	0	0
Non-designated derivative instruments:
Foreign currency contracts assets-current	0	0
Foreign currency contracts liabilities-current	0	0
Fair Value, Measurements, Recurring | Level I | Foreign currency contracts | Not Designated as Hedging Instrument
Designated derivative instruments:
Foreign currency contracts assets-current	0	0
Foreign currency contracts liabilities-current	0	0
Non-designated derivative instruments:
Foreign currency contracts assets-current	0	0
Foreign currency contracts liabilities-current	0	0
Fair Value, Measurements, Recurring | Level I | Interest rate contracts | Designated as Hedging Instrument
Designated derivative instruments:
Foreign currency contracts liabilities-current	0	0
Non-designated derivative instruments:
Foreign currency contracts liabilities-current	0	0
Fair Value, Measurements, Recurring | Level II
Cash equivalents:
Cash equivalents	249,594	316,662
Short-term investments:
Short-term investments	1,154,252	986,574
Total cash equivalents and short-term investments	1,403,846	1,303,236
Fair Value, Measurements, Recurring | Level II | Foreign currency contracts | Designated as Hedging Instrument
Designated derivative instruments:
Foreign currency contracts assets-current	2,918	2,541
Foreign currency contract assets-noncurrent	665	800
Foreign currency contracts liabilities-current	4,720	3,731
Foreign currency contracts liabilities-noncurrent	1,201	844
Non-designated derivative instruments:
Foreign currency contracts assets-current	2,918	2,541
Foreign currency contracts liabilities-current	4,720	3,731
Fair Value, Measurements, Recurring | Level II | Foreign currency contracts | Not Designated as Hedging Instrument
Designated derivative instruments:
Foreign currency contracts assets-current	745	2,132
Foreign currency contracts liabilities-current	3,492	1,748
Non-designated derivative instruments:
Foreign currency contracts assets-current	745	2,132
Foreign currency contracts liabilities-current	3,492	1,748
Fair Value, Measurements, Recurring | Level II | Interest rate contracts | Designated as Hedging Instrument
Designated derivative instruments:
Foreign currency contracts liabilities-current	1,428	3,829
Non-designated derivative instruments:
Foreign currency contracts liabilities-current	1,428	3,829
Fair Value, Measurements, Recurring | Level III
Cash equivalents:
Cash equivalents	0	0
Short-term investments:
Short-term investments	0	0
Total cash equivalents and short-term investments	0	0
Fair Value, Measurements, Recurring | Level III | Foreign currency contracts | Designated as Hedging Instrument
Designated derivative instruments:
Foreign currency contracts assets-current	0	0
Foreign currency contract assets-noncurrent	0	0
Foreign currency contracts liabilities-current	0	0
Foreign currency contracts liabilities-noncurrent	0	0
Non-designated derivative instruments:
Foreign currency contracts assets-current	0	0
Foreign currency contracts liabilities-current	0	0
Fair Value, Measurements, Recurring | Level III | Foreign currency contracts | Not Designated as Hedging Instrument
Designated derivative instruments:
Foreign currency contracts assets-current	0	0
Foreign currency contracts liabilities-current	0	0
Non-designated derivative instruments:
Foreign currency contracts assets-current	0	0
Foreign currency contracts liabilities-current	0	0
Fair Value, Measurements, Recurring | Level III | Interest rate contracts | Designated as Hedging Instrument
Designated derivative instruments:
Foreign currency contracts liabilities-current	0	0
Non-designated derivative instruments:
Foreign currency contracts liabilities-current	0	0
U.S. treasury securities
Short-term investments:
Short-term investments	313,955	257,021
U.S. treasury securities | Fair Value, Measurements, Recurring
Short-term investments:
Short-term investments	313,955	257,021
U.S. treasury securities | Fair Value, Measurements, Recurring | Level I
Short-term investments:
Short-term investments	0	0
U.S. treasury securities | Fair Value, Measurements, Recurring | Level II
Short-term investments:
Short-term investments	313,955	257,021
U.S. treasury securities | Fair Value, Measurements, Recurring | Level III
Short-term investments:
Short-term investments	0	0
U.S. government agency securities
Short-term investments:
Short-term investments	183,328	160,075
U.S. government agency securities | Fair Value, Measurements, Recurring
Short-term investments:
Short-term investments	183,328	160,075
U.S. government agency securities | Fair Value, Measurements, Recurring | Level I
Short-term investments:
Short-term investments	0	0
U.S. government agency securities | Fair Value, Measurements, Recurring | Level II
Short-term investments:
Short-term investments	183,328	160,075
U.S. government agency securities | Fair Value, Measurements, Recurring | Level III
Short-term investments:
Short-term investments	0	0
Corporate debt securities
Short-term investments:
Short-term investments	656,969	569,478
Corporate debt securities | Fair Value, Measurements, Recurring
Short-term investments:
Short-term investments	656,969	569,478
Corporate debt securities | Fair Value, Measurements, Recurring | Level I
Short-term investments:
Short-term investments	0	0
Corporate debt securities | Fair Value, Measurements, Recurring | Level II
Short-term investments:
Short-term investments	656,969	569,478
Corporate debt securities | Fair Value, Measurements, Recurring | Level III
Short-term investments:
Short-term investments	0	0
Money market funds
Cash equivalents:
Cash equivalents	1,172,163	956,932
Money market funds | Fair Value, Measurements, Recurring
Cash equivalents:
Cash equivalents	1,172,163	956,932
Money market funds | Fair Value, Measurements, Recurring | Level I
Cash equivalents:
Cash equivalents	1,172,163	956,932
Money market funds | Fair Value, Measurements, Recurring | Level II
Cash equivalents:
Cash equivalents	0	0
Money market funds | Fair Value, Measurements, Recurring | Level III
Cash equivalents:
Cash equivalents	0	0
U.S. treasury securities
Cash equivalents:
Cash equivalents	35,903	178,173
U.S. treasury securities | Fair Value, Measurements, Recurring
Cash equivalents:
Cash equivalents	35,903	178,173
U.S. treasury securities | Fair Value, Measurements, Recurring | Level I
Cash equivalents:
Cash equivalents	0	0
U.S. treasury securities | Fair Value, Measurements, Recurring | Level II
Cash equivalents:
Cash equivalents	35,903	178,173
U.S. treasury securities | Fair Value, Measurements, Recurring | Level III
Cash equivalents:
Cash equivalents	0	0
U.S. government agency securities
Cash equivalents:
Cash equivalents	107,239	57,549
U.S. government agency securities | Fair Value, Measurements, Recurring
Cash equivalents:
Cash equivalents	107,239	57,549
U.S. government agency securities | Fair Value, Measurements, Recurring | Level I
Cash equivalents:
Cash equivalents	0	0
U.S. government agency securities | Fair Value, Measurements, Recurring | Level II
Cash equivalents:
Cash equivalents	107,239	57,549
U.S. government agency securities | Fair Value, Measurements, Recurring | Level III
Cash equivalents:
Cash equivalents	0	0
Certificates of deposit
Cash equivalents:
Cash equivalents	106,452	80,940
Certificates of deposit | Fair Value, Measurements, Recurring
Cash equivalents:
Cash equivalents	106,452	80,940
Certificates of deposit | Fair Value, Measurements, Recurring | Level I
Cash equivalents:
Cash equivalents	0	0
Certificates of deposit | Fair Value, Measurements, Recurring | Level II
Cash equivalents:
Cash equivalents	106,452	80,940
Certificates of deposit | Fair Value, Measurements, Recurring | Level III
Cash equivalents:
Cash equivalents	$ 0	$ 0

Balance Sheet Components - Sche

Balance Sheet Components - Schedule of Property and Equipment (Details) - USD ($) $ in Thousands	Oct. 31, 2024	Jul. 31, 2024
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	$ 683,712	$ 633,432
Less: Accumulated depreciation and amortization	(274,707)	(250,311)
Total property and equipment, net	409,005	383,121
Hosting equipment
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	434,018	418,775
Capitalized internal-use software
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	232,092	197,769
Computers and equipment
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	7,081	6,741
Purchased software
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	1,103	1,102
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	1,077	1,071
Leasehold improvements
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	$ 8,341	$ 7,974

Balance Sheet Components - Narr

Balance Sheet Components - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Jul. 31, 2024
Acquired Finite-Lived Intangible Assets [Line Items]
Historical cost	$ 109,616		$ 109,616
Accumulated amortization	50,021		45,781
Depreciation and amortization expense	21,423	$ 13,962
Capitalization of development costs of software for internal-use	$ 157,178	129,138
Internet Protocol Addresses
Acquired Finite-Lived Intangible Assets [Line Items]
Useful life	10 years
Historical cost	$ 12,400		12,400
Accumulated amortization	3,200		$ 2,800
Capitalized internal-use software
Acquired Finite-Lived Intangible Assets [Line Items]
Capitalization of development costs of software for internal-use	$ 4,200	$ 2,900

Balance Sheet Components- Sched

Balance Sheet Components- Schedule of Accrued Compensation (Details) - USD ($) $ in Thousands	Oct. 31, 2024	Jul. 31, 2024
Property, Plant and Equipment [Abstract]
Accrued commissions	$ 22,045	$ 51,371
Accrued bonuses	33,372	53,452
Accrued payroll and related expenses	47,924	47,184
Employee stock purchase plan	23,038	8,803
Total accrued compensation	$ 126,379	$ 160,810

Business Combinations - Narrati

Business Combinations - Narrative (Details) - USD ($) $ in Thousands		3 Months Ended
	Aug. 31, 2023	Oct. 31, 2024	Jul. 31, 2024
Business Acquisition [Line Items]
Goodwill		$ 417,029	$ 417,029
Estimated useful life		4 years
Developed technology
Business Acquisition [Line Items]
Estimated useful life		4 years
Securelyshare Software Private Ltd.
Business Acquisition [Line Items]
Purchase price consideration	$ 5,300
Goodwill	3,200
Securelyshare Software Private Ltd. | Developed technology
Business Acquisition [Line Items]
Finite-lived intangibles	$ 2,800
Estimated useful life	5 years

Goodwill and Acquired Intangi_3

Goodwill and Acquired Intangible Assets - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Jul. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	$ 417,029		$ 417,029
Amortization expense of acquired intangible assets	$ 4,240	$ 3,036

Goodwill and Acquired Intangi_4

Goodwill and Acquired Intangible Assets - Schedule of Acquired Intangible Assets (Details) - USD ($) $ in Thousands	3 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Jul. 31, 2024
Gross Carrying Amount
Intangible Assets, Gross, beginning balance	$ 109,616
Additions	0
Intangible Assets, Gross, ending balance	109,616
Accumulated Amortization
Accumulated Amortization, beginning balance	(45,781)
Amortization Expense	(4,240)	$ (3,036)
Accumulated Amortization, ending balance	(50,021)
Net Carrying Amount
Total	$ 59,595		$ 63,835
Weighted Average Remaining Useful life	4 years
Developed technology
Gross Carrying Amount
Intangible Assets, Gross, beginning balance	$ 99,656
Additions	0
Intangible Assets, Gross, ending balance	99,656
Accumulated Amortization
Accumulated Amortization, beginning balance	(42,651)
Amortization Expense	(3,815)
Accumulated Amortization, ending balance	(46,466)
Net Carrying Amount
Total	$ 53,190		57,005
Weighted Average Remaining Useful life	4 years
Customer relationships
Gross Carrying Amount
Intangible Assets, Gross, beginning balance	$ 9,960
Additions	0
Intangible Assets, Gross, ending balance	9,960
Accumulated Amortization
Accumulated Amortization, beginning balance	(3,130)
Amortization Expense	(425)
Accumulated Amortization, ending balance	(3,555)
Net Carrying Amount
Total	$ 6,405		$ 6,830
Weighted Average Remaining Useful life	4 years 1 month 6 days

Goodwill and Acquired Intangi_5

Goodwill and Acquired Intangible Assets - Schedule of Future Amortization Expense (Details) - USD ($) $ in Thousands	Oct. 31, 2024	Jul. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
2025 (remaining nine months)	$ 12,545
2026	15,772
2027	12,948
2028	11,115
2029	7,215
Total	$ 59,595	$ 63,835

Derivative Instruments - Narrat

Derivative Instruments - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Jul. 31, 2024
Derivative [Line Items]
Unrealized gain related to our cash flow hedges	$ 2,700
Hedge accounting fair value adjustments	1,522		$ 4,065
Long-term Debt
Derivative [Line Items]
Hedged liability, fair value hedge	499,300		498,200
Foreign currency contracts | Not Designated as Hedging Instrument
Derivative [Line Items]
Notional amount	397,700		352,800
Foreign currency contracts | Designated as Hedging Instrument
Derivative [Line Items]
Notional amount	604,800		544,500
Interest Rate Swap
Derivative [Line Items]
Notional amount	$ 500,000		$ 500,000
Minimum | Foreign currency contracts | Not Designated as Hedging Instrument
Derivative [Line Items]
Term of derivative	1 month
Maximum
Derivative [Line Items]
Term of derivative	21 months
Maximum | Foreign currency contracts | Not Designated as Hedging Instrument
Derivative [Line Items]
Term of derivative		4 months

Derivative Instruments - Schedu

Derivative Instruments - Schedule of Changes of AOCI Related to our Cash Flow Hedges (Details) - USD ($) $ in Thousands	3 Months Ended
	Oct. 31, 2024	Oct. 31, 2023
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	$ 1,274,102	$ 725,112
Net unrealized gains (losses) recognized in accumulated other comprehensive income	469	(15,136)
(Gains) reclassified from AOCI into the condensed consolidated statement of operations	(1,208)	(654)
Ending balance	1,428,545	807,525
Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	(4,224)	8,937
Ending balance	$ (4,963)	$ (6,853)

Derivative Instruments - Sche_2

Derivative Instruments - Schedule of Cash Flow Hedges on our Consolidated Statement of Operations (Details) - USD ($) $ in Thousands	3 Months Ended
	Oct. 31, 2024	Oct. 31, 2023
Derivative Instruments, Gain (Loss) [Line Items]
Total	$ (1,208)	$ (654)
Cost of revenue
Derivative Instruments, Gain (Loss) [Line Items]
Total	(277)	(176)
Sales and marketing
Derivative Instruments, Gain (Loss) [Line Items]
Total	(672)	(295)
Research and development
Derivative Instruments, Gain (Loss) [Line Items]
Total	(161)	(92)
General and administrative
Derivative Instruments, Gain (Loss) [Line Items]
Total	$ (98)	$ (91)

Derivative Instruments - Sche_3

Derivative Instruments - Schedule of Derivative Instruments Designated as Fair Value Hedges (Details) - Gains (losses) on interest rate swaps: - USD ($) $ in Thousands	3 Months Ended
	Oct. 31, 2024	Oct. 31, 2023
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Hedge accounting fair value adjustments	$ (2,543)	$ (1,110)
Derivatives designated as hedging instruments	2,401	1,094
Total	$ (142)	$ (16)

Convertible Senior Notes - Narr

Convertible Senior Notes - Narrative (Details) - USD ($) $ / shares in Units, $ in Millions	Jun. 25, 2020	Oct. 31, 2024	Jul. 31, 2024
Debt Instrument [Line Items]
Proceeds from debt issuance	$ 1,130.5
Fair value of notes		$ 1,459.8	$ 1,465.5
Initial strike price (in dollars per share)	$ 150.80
Initial cap price (in dollars per shares)	$ 246.76
Convertible Senior Notes Due 2025
Debt Instrument [Line Items]
Principal amount	$ 1,150
Interest rate	0.125%
Convertible Senior Notes, $150 million
Debt Instrument [Line Items]
Principal amount	$ 150

Convertible Senior Notes - Carr

Convertible Senior Notes - Carrying Amounts (Details) - USD ($) $ in Thousands	Oct. 31, 2024	Jul. 31, 2024
Convertible Debt [Abstract]
Principal amount	$ 1,149,954	$ 1,149,954
Less:
Unamortized debt issuance costs	2,633	3,614
Hedge accounting fair value adjustments	1,522	4,065
Total	$ 1,145,799	$ 1,142,275

Convertible Senior Notes - Inte

Convertible Senior Notes - Interest Expense (Details) - USD ($) $ in Thousands	3 Months Ended
	Oct. 31, 2024	Oct. 31, 2023
Debt Disclosure [Abstract]
Contractual interest expense	$ 359	$ 359
Amortization of debt issuance costs	981	977
Total	$ 1,340	$ 1,336

Commitments and Contingencies (

Commitments and Contingencies (Details) $ in Millions	3 Months Ended
	Oct. 31, 2024 USD ($)
Third-Party Service Agreement
Loss Contingencies [Line Items]
Purchase obligation	$ 100
Purchase commitment, period (in years)	5 years
Bandwidth And Internet Service Agreements
Loss Contingencies [Line Items]
Purchase obligation	$ 27.1
Bandwidth And Internet Service Agreements | Minimum
Loss Contingencies [Line Items]
Purchase commitment, period (in years)	2 years
Bandwidth And Internet Service Agreements | Maximum
Loss Contingencies [Line Items]
Purchase commitment, period (in years)	3 years

Stock-Based Compensation - Sche

Stock-Based Compensation - Schedule of Stock Options (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		12 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Jul. 31, 2024
Outstanding Stock Options
Beginning balance (in shares)	453,000
Granted (in shares)	0	0
Exercised (in shares)	(87,000)
Canceled, forfeited or expired (in shares)	0
Ending balance (in shares)	366,000		453,000
Exercisable and expected to vest (in shares)	283,000		367,000
Weighted-Average Exercise Price
Beginning balance (in dollars per share)	$ 46.72
Granted (in dollars per share)	0
Exercised (in dollars per share)	10.19
Canceled, forfeited or expired (in dollars per share)	0
Ending balance (in dollars per share)	55.46		$ 46.72
Exercisable and expected to vest (in dollars per share)	$ 19.11		$ 15.84
Weighted-Average Remaining Contractual Term (in years)
Options outstanding, weighted average remaining contractual term	2 years 8 months 12 days		2 years 6 months
Exercisable and expected to vest, weighted average remaining contractual term	10 months 24 days		1 year
Aggregate Intrinsic Value
Options outstanding, aggregate intrinsic value	$ 46,604		$ 60,923
Exercised, aggregate intrinsic value	14,330	$ 23,200
Exercisable and expected to vest, aggregate intrinsic value	$ 45,707		$ 59,989

Stock-Based Compensation - Narr

Stock-Based Compensation - Narrative (Details) - USD ($)	3 Months Ended		12 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Jul. 31, 2024
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercised, aggregate intrinsic value	$ 14,330,000	$ 23,200,000
Granted (in shares)	0	0
Capitalized stock-based compensation	$ 12,400,000	$ 4,700,000
Employee Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares issued under ESPP (in shares)	0		$ 0
Employee Stock | 2018 Employee Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Accrued compensation	$ 23,000,000		$ 8,800,000

Stock-Based Compensation - Sc_2

Stock-Based Compensation - Schedule of RSU and PSA Activity (Details) - Restricted Stock Units and Performance Stock Awards $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Oct. 31, 2024 USD ($) $ / shares shares
Underlying Shares
Beginning balance (in shares) | shares	9,814
Granted (in shares) | shares	3,197
Vested (in shares) | shares	(838)
Canceled or forfeited (in shares) | shares	(423)
Ending balance (in shares) | shares	11,750
Weighted-Average Grant Date Fair Value
Beginning balance (in dollars per share) | $ / shares	$ 162.41
Granted (in dollars per share) | $ / shares	169.58
Vested (in dollars per share) | $ / shares	152.78
Canceled or forfeited (in shares) | $ / shares	167.99
Ending balance (in dollars per share) | $ / shares	$ 164.84
Aggregate Intrinsic Value
Beginning balance | $	$ 1,760,079
Vested | $	144,131
Ending balance | $	$ 2,124,164

Stock-Based Compensation - Stoc

Stock-Based Compensation - Stock-based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended
	Oct. 31, 2024	Oct. 31, 2023
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Stock-based compensation expense	$ 157,178	$ 129,138
Cost of revenue
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Stock-based compensation expense	15,226	12,584
Sales and marketing
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Stock-based compensation expense	63,179	56,630
Research and development
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Stock-based compensation expense	58,071	40,193
General and administrative
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Stock-based compensation expense	$ 20,702	$ 19,731

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended
	Oct. 31, 2024	Oct. 31, 2023
Income Tax Disclosure [Abstract]
Provision for income taxes	$ 7,637	$ 8,997

Net Loss Per Share - Schedule o

Net Loss Per Share - Schedule of Net Loss Per Share, Basic and Diluted (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Oct. 31, 2024	Oct. 31, 2023
Earnings Per Share [Abstract]
Net loss, basic	$ (12,051)	$ (33,483)
Net loss, diluted	$ (12,051)	$ (33,483)
Weighted-average shares used in computing net loss per share, basic (in shares)	152,557	147,625
Weighted-average shares used in computing net loss per share, diluted (in shares)	152,557	147,625
Net loss per share, basic (in dollars per share)	$ (0.08)	$ (0.23)
Net loss per share, diluted (in dollars per share)	$ (0.08)	$ (0.23)

Net Loss Per Share - Schedule_2

Net Loss Per Share - Schedule of Antidilutive Securities Excluded from Computation of Net Loss Per Share (Details) - shares shares in Thousands	3 Months Ended
	Oct. 31, 2024	Oct. 31, 2023
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	20,619	20,141
Number of shares if notes converted (in shares)	7,600
Unvested RSUs and shares of common stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	11,184	9,467
Stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	366	1,116
Unvested PSAs
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	947	867
Number of unvested PSAs as a percentage of target	100%	100%
Share purchase rights under the ESPP
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	496	1,065
Notes
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	7,626	7,626

Subsequent Events (Details)

Subsequent Events (Details) - Third-Party Service Agreement - USD ($) $ in Millions	1 Months Ended	3 Months Ended
	Nov. 30, 2024	Oct. 31, 2024
Subsequent Event [Line Items]
Purchase obligation		$ 100
Purchase commitment, period (in years)		5 years
Subsequent Event
Subsequent Event [Line Items]
Purchase obligation	$ 300
Purchase commitment, period (in years)	5 years